10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

FORM 10-Q

(Mark One)

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended April 3, 2021

OR

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______________ to _______________

Commission file number: 1-10245

RCM TECHNOLOGIES, INC.

(Exact Name of Registrant as Specified in Its Charter)

Nevada	95--1480559
(State or other Jurisdiction of Incorporation)	(I.R.S. Employer Identification No.)

2500 McClellan Avenue, Suite 350, Pennsauken, New Jersey  08109-4613

(Address of Principal Executive Offices)                                           (Zip Code)

(856) 356-4500

(Registrant’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.05 per share	RCMT	The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  YES [X]     NO [  ]

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  YES [X]     NO [  ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company.  (See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act).  (Check one):

Large Accelerated Filer [  ] Accelerated Filer [  ] Non-Accelerated Filer [X] Smaller Reporting Company [X] Emerging Growth Company [  ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  [  ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

YES [  ]     NO [X]

Indicate the number of shares outstanding of the Registrant’s class of common stock, as of the latest practicable date.

Common Stock, $0.05 par value, 11,089,084 shares outstanding as of May 13, 2021.

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

PART I - FINANCIAL INFORMATION
		Page
Item 1.	Condensed Consolidated Financial Statements
	Condensed Consolidated Balance Sheets as of April 3, 2021 (Unaudited) and January 2, 2021	4
	Unaudited Condensed Consolidated Statements of Operations for the Thirteen Week Periods Ended April 3, 2021 and March 28, 2020	5
	Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss) for the Thirteen Week Periods Ended April 3, 2021 and March 28, 2020	6
	Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity for the Thirteen Week Periods Ended April 3, 2021 and March 28, 2020	7
	Unaudited Condensed Consolidated Statements of Cash Flows for the Thirteen Week Periods Ended April 3, 2021 and March 28, 2020	8
	Notes to Unaudited Condensed Consolidated Financial Statements	9
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	30
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	44
Item 4.	Controls and Procedures	44
PART II - OTHER INFORMATION
Item 1.	Legal Proceedings	45
Item 1A.	Risk Factors	45
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	45
Item 3.	Defaults Upon Senior Securities	45
Item 4.	Mine Safety Disclosures	45
Item 5.	Other Information	45
Item 6.	Exhibits	46
Signatures		47

2

CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS

This report and documents incorporated by reference into it may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are not historical facts but rather are based on current expectations, estimates and projections about our business and industry, and our beliefs and assumptions. Words such as “believes,” “anticipates,” “plans,” “expects,” “will,” “goal,” and similar expressions are intended to identify forward-looking statement. The inclusion of forward-looking statements should not be regarded as a representation by us that any of our plans will be achieved. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Such forward-looking information is also subject to various risks and uncertainties. Such risks and uncertainties include, but are not limited to, risks arising from our providing service to the healthcare industry; the impact of and future effects of the COVlD-19 pandemic or other potential pandemics; having a significant portion of our condensed consolidated revenues contributed by a concentrated group of customer during the thirteen week period ended April 3, 2021; credit and collection risks; our claim experience related to workers’ compensation and general liability insurance; the effects of changes in, or interpretations of laws and regulations governing, the healthcare industry, our workforce and the services that we provide, including state and local regulations pertaining to the taxability of our services and other labor-related matters such a minimum wage increases; the Company’s expectations with respect to selling, general, and administrative expense; and the risk factors described in Part I, Item 1A, “Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended January 2, 2021 and Part II, Item 1A “Risk Factors” of subsequent Quarterly Reports on Form 10-Q, including this Form 10-Q.

3

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

April 3, 2021 and January 2, 2021

(In thousands, except share and per share amounts)

			April 3,	January 2,
			2021	2021
			(Unaudited)
Current assets:
	Cash and cash equivalents		$678	$734
	Accounts receivable, net		45,282	36,007
	Transit accounts receivable		3,947	2,494
	Prepaid expenses and other current assets		4,201	4,699
		Total current assets	54,108	43,934
Property and equipment, net			1,859	2,078
Other assets:
	Deposits		169	169
	Deferred tax asset, net, domestic		3,002	3,300
	Goodwill		16,354	16,354
	Operating right of use asset		2,263	2,409
	Intangible assets, net		15	95
		Total other assets	21,803	22,327
		Total assets	$77,770	$68,339

Current liabilities:
	Accounts payable and accrued expenses			$7,326		$7,895
	Transit accounts payable			4,551		4,900
	Accrued payroll and related costs			12,894		12,877
	Finance lease payable			183		247
	Income taxes payable			351		436
	Operating right of use liability			1,937		1,886
	Liability for contingent consideration from acquisitions			520		500
			Total current liabilities	27,762		28,741
Deferred tax liability, foreign				369		365
Finance lease payable				96		106
Liability for contingent consideration from acquisitions				2,364		2,358
Operating right of use liability, net of current position				2,224		2,641
Borrowings under line of credit				22,029		11,890
		Total liabilities		54,844		46,101
Commitments and contingencies (note 16)
Stockholders’ equity:
	Preferred stock, $1.00 par value; 5,000,000 shares authorized;
			no shares issued or outstanding	-		-
	Common stock, $0.05 par value; 40,000,000 shares authorized;
			16,510,793 shares issued and 11,485,310 shares outstanding at April 3, 2021 and 16,224,191 shares issued and 11,542,880 shares outstanding at January 2, 2021	826		811
			Stock subscription receivable	(323	)	(420	)
	Additional paid-in capital			110,179		109,588
	Accumulated other comprehensive loss			(2,661	)	(2,550)
	Accumulated deficit			(66,967	)	(67,974	)
	Treasury stock (5,025,483 shares at April 3, 2021 and
			(4,681,311 shares at January 2, 2021) at cost	(18,128	)	(17,217	)
			Stockholders’ equity	22,926		22,238
			Total liabilities and stockholders’ equity	$77,770		$68,339

4

The accompanying notes are an integral part of these condensed consolidated financial statements.

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

Thirteen Week Periods Ended April 3, 2021 and March 28, 2020

(Unaudited)

(In thousands, except per share amounts)

		Thirteen Weeks Ended
		April 3, 2021		March 28, 2020
Revenue		$44,549		$45,033
Cost of services		33,699		34,190
Gross profit		10,850		10,843
Operating costs and expenses
	Selling, general and administrative	9,069		10,237
	Depreciation and amortization of property    and equipment	266		255
	Amortization of acquired intangible assets	80		80
	Write-off of receivables and professional fees    incurred related to arbitration	-		8,047
	Tax credit professional fees	60		-
Operating costs and expenses		9,475		18,619
Operating income (loss)		1,375		(7,776	)
Other expense (income)
	Interest expense and other, net	121		340
	Change in fair value of contingent consideration	26		36
	Loss (gain) on foreign currency transactions	(135	)	33
Other expense, net		12		409
Income (loss) before income taxes		1,363		(8,185	)
Income tax expense (benefit)		356		(2,240	)
Net income (loss)		$1,007		($5,945	)
Basic net earnings (loss) per share		$0.09		($0.45	)
Diluted net earnings (loss) per share		$0.08		($0.45	)

5

The accompanying notes are an integral part of these condensed consolidated financial statements.

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

Thirteen Week Periods Ended April 3, 2021 and March 28, 2020

(Unaudited)

(In thousands)

	April 3, 2021		March 28, 2020
Net income (loss)	$1,007		($5,945	)
Other comprehensive loss	(111	)	(131	)
Comprehensive income (loss)	$896		($6,076	)

6

The accompanying notes are an integral part of these condensed consolidated financial statements.

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

Thirteen Week Period Ended April 3, 2021

(Unaudited)

(In thousands, except share amounts)

	Common Stock		Stock Subscription Receivable		Additional Paid-in Capital		Accumulated Other Comprehensive Loss		Accumulated Deficit		Treasury Stock			Total
	Issued Shares	Amount									Shares	Amount
Balance, January 2, 2021	16,224,191	$811	($420	)	$109,588		($2,550	)	($67,974	)	4,681,311	($17,217	)	$22,238
Issuance of stock under    employee stock purchase plan	53,906	3	-		58		-		-		-	-		61
Stock subscription receivable	57,696	3	97		(3	)	-		-		-	-		97
Equity compensation expense from    awards issued	-	-	-		545		-		-		-	-		545
Issuance of stock upon vesting    of restricted share awards	175,000	9	-		(9	)	-		-		-	-		-
Purchase of treasury stock	-	-	-		-		-		-		344,172	(911	)	(911	)
Foreign currency translation    adjustment	-	-	-		-		(111	)	-		-	-		(111	)
Net income	-	-	-		-		-		1,007		-	-		1,007
Balance, April 3, 2021	16,510,793	$826	($323	)	$110,179		($2,661	)	($66,967	)	5,025,483	($18,128	)	$22,926

	Common Stock		Additional Paid-in Capital	Accumulated Other Comprehensive Loss		Accumulated Deficit		Treasury Stock			Total
	Issued Shares	Amount						Shares	Amount
Balance, December 28, 2019	15,826,891	$791	$108,452	($2,748	)	($59,105	)	2,823,172	($14,987	)	$32,403
Issuance of stock under    employee stock purchase plan	57,251	3	137	-		-		-	-		140
Issuance of equity awards	60,000	3	(3)	-		-		-	-		-
Share-based compensation expense	-	-	69	-		-		-	-		69
Foreign currency translation    adjustment	-	-	-	(131	)	-		-	-		(131	)
Net loss	-	-	-	-		(5,945	)	-	-		(5,945	)
Balance, March 28, 2020	15,944,142	$797	$108,655	($2,879	)	($65,050	)	2,823,172	($14,987	)	$26,536

7

The accompanying notes are an integral part of these condensed consolidated financial statements.

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

Thirteen Week Periods Ended April 3, 2021 and March 28, 2020

 (Unaudited)

(In thousands)

				April 3, 2021		March 28, 2020
Cash flows from operating activities:
	Net income (loss)			$1,007		($5,945	)
	Adjustments to reconcile net income to net cash provided by    (used in) operating activities:
		Depreciation and amortization		346		335
		Change in fair value of contingent consideration		26		36
		Equity compensation expense		362		69
		Provision for losses on accounts receivable		(150	)	7,792
		Deferred income tax expense (benefit)		302		(2,217	)
		Changes in assets and liabilities:
			Accounts receivable	(9,085	)	974
			Prepaid expenses and other current assets	582		166
			Net of transit accounts receivable and payable	(1,802	)	973
			Accounts payable and accrued expenses	(588	)	(6	)
			Accrued payroll and related costs	187		(1,289	)
			Right of use assets	146		304
			Right of use liabilities	(366	)	(284	)
			Income taxes payable	(157	)	21
	Total adjustments			(10,197	)	6,874
	Net cash (used in) provided by operating activities			(9,190	)	929
Cash flows from investing activities:
	Property and equipment acquired			(47	)	(35	)
	Net cash used in investing activities			(47	)	(35	)
Cash flows from financing activities:
	Borrowings under line of credit			26,186		22,279
	Repayments under line of credit			(16,046	)	(24,273	)
	Issuance of stock for employee stock purchase plan			60		140
	Stock subscription			97		-
	Changes in finance lease obligations			(71	)	(80	)
	Common stock repurchase			(911	)	-
	Net cash provided by (used in) financing activities			9,315		(1,934	)
Effect of exchange rate changes on cash and cash equivalents				(134	)	(165	)
Decrease in cash and cash equivalents				(56	)	(1,205	)
Cash and cash equivalents at beginning of period				734		1,847
Cash and cash equivalents at end of period				$678		$642
Supplemental cash flow information:
	Cash paid for:
		Interest		$254		$420
		Income taxes		$236		$43
Non-cash financing activities:
	Equity awards issued			$380		$172

8

The accompanying notes are an integral part of these condensed consolidated financial statements.

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts, unless otherwise indicated)

1. Basis of Presentation

The accompanying condensed consolidated interim financial statements of RCM Technologies, Inc. and subsidiaries (“RCM” or the “Company”) are unaudited. The year-end consolidated balance sheet was derived from audited statements but does not include all disclosures required by accounting principles generally accepted in the United States. These statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission pertaining to reports on Form 10-Q and should be read in conjunction with the Company’s consolidated financial statements and the notes thereto for the year ended January 2, 2021 included in the Company’s Annual Report Form 10-K for such period. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations.

The condensed consolidated financial statements for the unaudited interim periods presented include all adjustments (consisting only of normal, recurring adjustments) necessary for a fair presentation of financial position, results of operations and cash flows for such interim periods.

Results for the thirteen week period ended April 3, 2021 are not necessarily indicative of results that may be expected for the full year.

Fiscal Year

The Company follows a 52/53 week fiscal reporting calendar ending on the Saturday closest to December 31.  The current fiscal year ended January 1, 2022 (fiscal 2021) is a 52-week reporting year.  The prior fiscal year ending January 2, 2021 (fiscal 2020) was a 53-week reporting year.  The fiscal quarters for the current year (fiscal 2021) and the prior year (fiscal 2020) align as follows:

Fiscal 2021 Quarters	Weeks	Fiscal 2020 Quarters	Weeks
April 3, 2021	Thirteen	March 28, 2020	Thirteen
July 3, 2021	Thirteen	June 27, 2020	Thirteen
October 2, 2021	Thirteen	September 26, 2020	Thirteen
January 1, 2022	Thirteen	January 2, 2021	Fourteen

Current Liquidity and Revolving Credit Facility

Liquidity is a measure of our ability to meet potential cash requirements, maintain our assets, fund our operations, and meet the other general cash needs of our business. Our liquidity is impacted by general economic, financial, competitive, and other factors beyond our control. Our liquidity requirements consist primarily of funds necessary to pay our expenses, principally labor-costs, and other related expenditures. We generally satisfy our liquidity needs through cash provided by operations and, when necessary, our revolving line of credit from Citizens Bank. The Company believes it has a great deal of flexibility to reduce its costs if it becomes necessary. The Company believes that it can satisfy its liquidity needs for at least the next twelve months.

The Company’s liquidity and capital resources as of April 3, 2021, included accounts receivable and total current asset balances of $45.3 million and $54.1 million, respectively. Current liabilities were $28.0 million as of April 3, 2021 and total current assets exceeded total current liabilities by $26.1 million.

9

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts, unless otherwise indicated)

1. Basis of Presentation (Continued)

Current Liquidity and Revolving Credit Facility (Continued)

The Company experiences volatility in its daily cash flow and, at times, relies on the revolving line of credit to provide daily liquidity for the Company’s financial operations.  As of April 3, 2021, the Company was in compliance with all financial covenants contained in the revolving line of credit.  The Company believes that it will maintain compliance with its financial covenants for the foreseeable future. 

2. Use of Estimates and Uncertainties

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenue and expenses and disclosure of contingent assets and liabilities.  Actual results could differ from those estimates.

The Company uses estimates to calculate an allowance for doubtful accounts on its accounts receivables, adequacy of reserves, goodwill impairment, if any, equity compensation, the tax rate applied and the valuation of certain assets and liability accounts.  These estimates can be significant to the operating results and financial position of the Company.  The estimates are based upon various factors including current and historical trends, as well as other pertinent industry and regulatory authority information, including the potential future effects of COVID-19.  Management regularly evaluates this information to determine if it is necessary to update the basis for its estimates and to adjust for known changes.

The Company has risk participation arrangements with respect to workers compensation and health care insurance.  The amounts included in the Company’s costs related to this risk participation are estimated and can vary based on changes in assumptions, the Company’s claims experience or the providers included in the associated insurance programs.

The Company can be affected by a variety of factors including uncertainty relating to the performance of the general economy, competition, demand for the Company’s services, adverse litigation and claims and the hiring, training and retention of key employees.

Fair Value of Financial Instruments

The Company’s carrying value of financial instruments, consisting primarily of accounts receivable, transit accounts receivable, accounts payable and accrued expenses, and transit accounts payable and borrowings under line of credit approximates fair value due to their liquidity or their short-term nature and the line of credit’s variable interest rate.  The Company does not have derivative products in place to manage risks related to foreign currency fluctuations for its foreign operations or for interest rate changes.

The Company re-measures the fair value of the contingent consideration at each reporting period and any change in the fair value from either the passage of time or events occurring after the acquisition date, is recorded in earnings in the accompanying consolidated statement of operations.

10

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts, unless otherwise indicated)

3. Revenue Recognition

The Company records revenue under Accounting Standards Codification ("ASC") Topic 606, Revenue from Contracts with Customers.  Revenue is recognized when we satisfy a performance obligation by transferring services promised in a contract to a customer, in an amount that reflects the consideration that we expect to receive in exchange for those services.  Performance obligations in our contracts represent distinct or separate service streams that we provide to our customers.

We evaluate our revenue contracts with customers based on the five-step model under ASC 606: (1) Identify the contract with the customer; (2) Identify the performance obligations in the contract; (3) Determine the transaction price; (4) Allocate the transaction price to separate performance obligations; and (5) Recognize revenue when (or as) each performance obligation is satisfied.

The Company derives its revenue from several sources.  The Company’s Engineering Services and Information Technology segments perform consulting and project solution services.  The Healthcare segment specializes in long-term and short-term staffing and placement services to hospitals, schools and long-term care facilities amongst others.  All of the Company’s segments perform staff augmentation services and derive revenue from permanent placement fees.  The majority of the Company’s revenue is invoiced on a time and materials basis.

The following table presents our revenue disaggregated by revenue source for the thirteen week periods ended April 3, 2021 and March 28, 2020:

	Thirteen Week Periods Ended
	April 3, 2021	March 28, 2020
Engineering:
Time and Material	$10,478	$12,827
Fixed Fee	3,921	1,314
Permanent Placement Services	67	22
Total Engineering	$14,466	$14,163
Specialty Health Care:
Time and Material	$20,933	$22,053
Permanent Placement Services	204	144
Total Specialty Health Care	$21,137	$22,197
Information Technology:
Time and Material	$8,796	$8,557
Permanent Placement Services	150	116
Total Information Technology	$8,946	$8,673
	$44,549	$45,033

11

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts, unless otherwise indicated)

3.Revenue Recognition (Continued)

Time and Material

The Company’s IT and Healthcare segments predominantly recognize revenue through time and material work while its Engineering segment recognizes revenue through both time and material and fixed fee work. The Company’s time and material contracts are typically based on the number of hours worked at contractually agreed upon rates, therefore revenue associated with these time and materials contracts are recognized based on hours worked at contracted rates. 

Fixed Fee

From time to time and predominantly in our Engineering segment, the Company will enter into contracts requiring the completion of specific deliverables.  The Company has master services agreements with many of its customers that broadly define terms and conditions. Actual services performed under fixed fee arrangements are typically delivered under purchase orders that more specifically define terms and conditions related to that fixed fee project. While these master services agreements can often span several years, the Company’s fixed fee purchase orders are typically performed over six to nine month periods.  In instances where project services are provided on a fixed-price basis, revenue is recorded in accordance with the terms of each contract.  In certain instances, revenue is invoiced at the time certain milestones are reached, as defined in the contract.  Revenue under these arrangements are recognized as the costs on these contracts are incurred.  On an infrequent basis, amounts paid in excess of revenue earned and recognized are recorded as deferred revenue, included in accounts payable and accrued expenses on the accompanying condensed balance sheets.  Additionally, some contracts contain “Performance Fees” (bonuses) for completing a contract under budget.  Performance Fees, if any, are recorded when earned.  Some contracts also limit revenue and billings to specified maximum amounts.  Provisions for contract losses, if any, are made in the period such losses are determined.  For contracts where there is a specific deliverable and the work is not complete and the revenue is not recognized, the costs incurred are deferred as a prepaid asset.  The associated costs are expensed when the related revenue is recognized.

Permanent Placement Services

The Company earns permanent placement fees from providing permanent placement services.  These fees are typically based on a percentage of the compensation paid to the person placed with the Company’s client.

There was $0.1 million deferred revenue as of April 3, 2021.  Deferred revenue was $0.4 million as of January 2, 2021 and was included in accounts payable and accrued expenses in the accompanying condensed consolidated balance sheet at that date.  Revenue is recognized when the service has been performed.  Deferred revenue may be recognized over a period exceeding one year from the time it was recorded on the balance sheet.  For the thirteen week periods ended April 3, 2021 and March 28, 2020, the Company recognized $0.3 million and $0.4 million that was included in deferred revenue at the beginning of each respective reporting period.

12

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts, unless otherwise indicated)

4. Accounts Receivable, Transit Accounts Receivable and Transit Accounts Payable

The Company’s accounts receivable are comprised as follows:

	April 3, 2021		January 2, 2021
Billed	$31,529		$25,926
Accrued and unbilled	11,636		8,219
Work-in-progress	3,535		3,612
Allowance for sales discounts and doubtful accounts	(1,418	)	(1,750	)
Accounts receivable, net	$45,282		$36,007

Unbilled receivables primarily represent revenue earned whereby those services are ready to be billed as of the balance sheet ending date.  Work-in-progress primarily represents revenue earned under contracts which the Company contractually invoices at future dates.

From time to time, the Company’s Engineering segment enters into agreements to provide, among other things, construction management and engineering services.  Pursuant to these agreements, the Company a) may engage subcontractors to provide construction or other services; b) typically earns a fixed percentage of the total project value; and c) assumes no ownership or risks of inventory.  Under the terms of the agreements, the Company is typically not required to pay the subcontractor until after the corresponding payment from the Company’s end-client is received. Upon invoicing the end-client on behalf of the subcontractor or staffing agency the Company records this amount simultaneously as both a “transit account receivable” and “transit account payable” as the amount when paid to the Company is due to and generally paid to the subcontractor within a few days. The Company typically does not pay a given transit account payable until the related transit account receivable is collected. The Company is typically obligated to pay the subcontractor or staffing agency whether or not the client pays the Company.  The Company’s transit accounts payable generally exceeds the Company’s transit accounts receivable but absolute amounts and spreads fluctuate significantly from quarter to quarter in the normal course of business.  The transit accounts receivable was $3.9 million and related transit accounts payable was $4.5 million, for a net payable of $0.6 million, as of April 3, 2021.  The transit accounts receivable was $2.5 million and related transit accounts payable was $4.9 million, for a net payable of $2.4 million, as of January 2, 2021.

13

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts, unless otherwise indicated)

5. Property and Equipment

Property and equipment are stated at cost and are depreciated on the straight-line method at rates calculated to provide for retirement of assets at the end of their estimated useful lives.  The annual rates are 20% for computer hardware and software as well as furniture and office equipment.  Leasehold improvements are amortized over the shorter of the estimated life of the asset or the lease term.

Property and equipment are comprised of the following:

	April 3, 2021	January 2, 2021
Computers and systems	$4,410	$4,686
Equipment and furniture	137	264
Leasehold improvements	234	235
	4,781	5,185
Less: accumulated depreciation and amortization	2,922	3,107
Property and equipment, net	$1,859	$2,078

The Company periodically writes off fully depreciated and amortized assets.  The Company wrote off fully depreciated and amortized assets of $451 and $960 during the thirteen week periods ended April 3, 2021 and March 28, 2020, respectively.  Depreciation and amortization expense of property and equipment for the thirteen week periods ended April 3, 2021 and March 28, 2020 was $266 and $255, respectively.

6. Acquisitions

The Company has acquired numerous companies throughout its history and those acquisitions have generally included significant future contingent consideration.  The Company gives no assurance that it will make acquisitions in the future or that if it does make acquisitions, such acquisitions will be successful.

Future Contingent Payments

As of April 3, 2021, the Company had two active acquisition agreements whereby additional contingent consideration may be earned by the former shareholders: 1) effective October 1, 2017, the Company acquired all of the stock of PSR Engineering Solutions d.o.o. Beograd (Voždovac) (“PSR”) and 2) effective September 30, 2018, the Company acquired certain assets of Thermal Kinetics Engineering, PLLC and Thermal Kinetics Systems, LLC (together, “TKE”). The Company estimates future contingent payments at April 3, 2021 as follows:

Fiscal Year Ending	Total
January 1, 2022 (after April 3, 2021)	$520
December 31, 2022	2,364
Estimated future contingent consideration payments	$2,884

14

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts, unless otherwise indicated)

6. Acquisitions (Continued)

Future Contingent Payments (Continued)

Estimates of future contingent payments are subject to significant judgment and actual payments may materially differ from estimates.  Potential future contingent payments to be made to all active acquisitions after April 3, 2021 are capped at a cumulative maximum of $3.1 million.  The Company estimates future contingent consideration payments based on forecasted performance and recorded the fair value of those expected payments as of April 3, 2021.  During the thirteen week period ended April 3, 2021, the Company measured contingent consideration at fair value on a non-recurring basis.  Contingent consideration related to acquisitions is recorded at fair value (level 3) due to the lack of observable market inputs. Changes in fair value are recorded in other (expense) income, net.

For acquisitions that involve contingent consideration, the Company records a liability equal to the fair value of the estimated contingent consideration obligation as of the acquisition date. The Company determines the acquisition date fair value of the contingent consideration based on the likelihood of paying the additional consideration. The fair value is estimated using projected future operating results and the corresponding future earn-out payments that can be earned upon the achievement of specified operating objectives and financial results by acquired companies using Level 3 inputs and the amounts are then discounted to present value. These liabilities are measured quarterly at fair value, and any change in the fair value of the contingent consideration liability is recognized in the consolidated statements of operations. During the measurement period, which may be up to one year from the acquisition date, the Company records adjustments to the assets acquired and liabilities assumed with the corresponding adjustment to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recognized in the consolidated statements of operations.

The Company did not pay contingent consideration during the thirteen week periods ended April 3, 2021 and March 28, 2020.

7. Goodwill

Goodwill represents the premium paid over the fair value of the net tangible and intangible assets acquired in business combinations.  The Company tests goodwill for impairment on an annual basis as of the last day of the Company's fiscal year or more frequently if events occur or circumstances change indicating that the fair value of goodwill may be below the carrying amount.  During the thirteen week period ended April 3, 2021, the Company reviewed the carrying value of goodwill due to the events and circumstances surrounding the COVID-19 pandemic.  While COVID-19 has negatively impacted the Company, and the Company expects this negative impact to continue at least through the first half of fiscal 2021 and likely beyond, the Company did not conclude in such review that this negative impact is permanent.  The Company has determined that no other indicators of impairment of goodwill existed during the thirteen week period ended April 3, 2021.  As such, no impairment loss on the Company’s goodwill during the thirteen week period ended April 3, 2021 was recorded as a result of such review.

The carrying amount of goodwill as of April 3, 2021 and January 2, 2021 is as follows:

Engineering	Specialty Health Care	Information Technology	Total
$11,918	$2,398	$2,038	$16,354

15

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts, unless otherwise indicated)

8. Intangible Assets

The Company evaluates long-lived assets and intangible assets with definite lives for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  When the Company determines that it is probable that undiscounted future cash flows will not be sufficient to recover an asset’s carrying amount, the asset is written down to its fair value.  Assets to be disposed of by sale, if any, are reported at the lower of the carrying amount or fair value less cost to sell.  The Company’s intangible assets consist of customer relationships and non-compete agreements.  During the thirteen week period ended April 3, 2021, the Company reviewed the carrying value of its intangible assets due to the events and circumstances surrounding the COVID-19 pandemic.  While COVID-19 has negatively impacted the Company, and the Company expects this negative impact to continue at least through the balance of fiscal 2021, the Company does not believe at this time that this negative impact is permanent. As such, no impairment loss on the Company’s intangible assets during the thirteen week period ended April 3, 2021 was recorded as a result of such review.

All of the Company’s intangible assets are associated with the Engineering segment.  Intangible assets other than goodwill are amortized over their useful lives.  Intangible assets are carried at cost, less accumulated amortization.

Details of intangible assets by class at April 3, 2021 and January 2, 2021:

	April 3, 2021	January 2, 2021
Restricted covenants	$8	$12
Customer relationships	7	83
Total intangible assets	$15	$95

Amortization expense of acquired intangible assets for both of the thirteen week periods ended April 3, 2021 and March 28, 2020 was $80.

9. Line of Credit

The Company and its subsidiaries amended and restated its Revolving Credit Facility with Citizens Bank of Pennsylvania on October 18, 2019.  As amended and restated, the Revolving Credit Facility provides for a $45.0 million revolving credit facility, has no sub-limit for letters of credit, and expires on August 8, 2023.

On September 29, 2020, the Company entered into an amendment to its Revolving Credit Facility. The amendment (i) modifies certain aspects of the financial covenants under the Loan Agreement, including the manner in which the measurement periods for certain components of the financial covenants are determined, (ii) modifies the required compliance levels for certain ratios under the Loan Agreement, and (iii) permitted the repayment of $2.2 million of indebtedness to a third party incurred in connection with the previously disclosed June 2020 repurchase of stock.

16

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts, unless otherwise indicated)

9. Line of Credit (Continued)

Borrowings under the Revolving Credit Facility bear interest at one of two alternative rates, as selected by the Company at each incremental borrowing.  These alternatives are: (i) LIBOR (London Interbank Offered Rate), plus applicable margin, typically borrowed in fixed 30-day increments or (ii) the agent bank’s prime rate generally borrowed over shorter durations.  The Company also pays unused line fees based on the amount of the Revolving Credit Facility that is not drawn.  Unused line fees are recorded as interest expense.  The effective weighted average interest rate, including unused line fees, for the thirteen week periods ended April 3, 2021 and March 28, 2020 were 2.4% and 3.7%, respectively.

All borrowings under the Revolving Credit Facility are collateralized by all of the assets of the Company and its subsidiaries and a pledge of the stock of its subsidiaries.  The Revolving Credit Facility also contains various financial and non-financial covenants, such as a covenant that restricts the Company’s ability to borrow in order to pay dividends.  As of April 3, 2021, the Company was in compliance with all covenants contained in the Revolving Credit Facility (as amended).The Company believes that it will maintain compliance with its financial covenants for the foreseeable future.

Borrowings under the line of credit as of April 3, 2021 and January 2, 2021 were $22.0 million and $11.9 million, respectively.  At both April 3, 2021 and January 2, 2021 there were letters of credit outstanding for $1.9 million.  At April 3, 2021 and January 2, 2021, the Company had availability for additional borrowings under the Revolving Credit Facility of $21.1 million and $31.2 million, respectively.

Impact to Line of Credit from COVID-19

The Company is negatively impacted by COVID-19 as more fully described in Footnote 19.  The Company believes that its current line of credit is adequate to provide the necessary liquidity while COVID-19 impacts its operations.  While the Company does expect to be in compliance with its financial covenants in the line of credit for the foreseeable future, the Company can give no assurance that the line of credit will be available to the Company.

10. Per Share Data

The Company uses the treasury stock method to calculate the weighted-average shares used for diluted earnings per share.  The number of common shares used to calculate basic and diluted earnings (loss) per share for the thirteen week periods ended April 3, 2021 and March 28, 2020 was determined as follows:

	Thirteen Week Periods Ended
	April 3, 2021	March 28, 2020
Basic weighted average shares outstanding	11,539,389	13,111,550
Dilutive effect of outstanding restricted share awards	389,857	-
Weighted average dilutive shares outstanding	11,929,246	13,111,550

17

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts, unless otherwise indicated)

10. Per Share Data (Continued)

For all periods presented, there were no anti-dilutive shares not included in the calculation of common stock equivalents as there were no stock options outstanding.

Unissued shares of common stock were reserved for the following purposes:

	April 3, 2021	January 2, 2021
Time-based restricted stock units outstanding	506,554	459,805
Unvested subscription restricted share awards	192,304	250,000
Performance-based restricted stock units outstanding	90,000	-
Future grants of options or shares	209,180	520,929
Shares reserved for employee stock purchase plan	95,988	149,894
Total	1,094,026	1,380,628

11. Share-Based Compensation

At April 3, 2021, the Company had two share-based employee compensation plans.  The Company measures the fair value of share-based awards, if and when granted, based on the Black-Scholes method and using the closing market price of the Company’s common stock on the date of grant.  Awards typically vest over periods ranging from one to three years and expire within 10 years of issuance.  The Company may also issue immediately vested equity awards.  Share-based compensation expense related to time-based awards is amortized in accordance with applicable vesting periods using the straight-line method.  The Company expenses performance-based awards only when the performance metrics are likely to be achieved and the associated awards are therefore likely to vest.  Performance-based share awards that are likely to vest are also expensed on a straight-line basis over the vesting period but may vest on a retroactive basis or be reversed, depending on when it is determined that they are likely to vest, or in the case of a reversal when they are later determined to be unlikely to vest.

Share-based compensation expense for the thirteen week periods ended April 3, 2021, and March 28, 2020 was $362 and $69, respectively.  As of April 3, 2021, there were 90,000 performance-based restricted stock units outstanding.

As of April 3, 2021, the Company had $1.1 million of total unrecognized compensation cost related to all time-based non-vested share-based awards outstanding. The Company expects to recognize this expense over approximately two years.  These amounts do not include a) performance-based restricted stock units, b) the cost of any additional share-based awards granted in future periods or c) the impact of any potential changes in the Company’s forfeiture rate. 

18

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts, unless otherwise indicated)

11. Share-Based Compensation (Continued)

Incentive Share-Based Plans

2014 Omnibus Equity Compensation Plan (the 2014 Plan)

The 2014 Plan, approved by the Company’s shareholders in December 2014, initially provided for the issuance of up to 625,000 shares of the Company’s common stock to officers, non-employee directors, employees of the Company and its subsidiaries, or consultants and advisors utilized by the Company.  In fiscal 2016 and fiscal 2020, the Company amended and restated the 2014 Plan with shareholder approval to increase the aggregate number of shares of stock reserved for issuance under the Plan by an additional 500,000 and 850,000 shares, respectively, so that the total number of shares of stock reserved for issuance under the Plan is 1,975,000 shares.  The expiration date of the Plan is December 17, 2030, unless the 2014 Plan is terminated earlier by the Board or is extended by the Board with the approval of the stockholders.  The Compensation Committee of the Board of Directors determines the vesting period at the time of grant. 

As of April 3, 2021, under the 2014 Plan, 698,858 time-based shares were outstanding, there were 90,000 performance-based restricted share units outstanding and 209,180 shares were available for awards thereunder.

The market value of equity grants issued for the thirteen week periods ended April 3, 2021 and March 28, 2020 was $835 and $423 respectively. 

Employee Stock Purchase Plan

The Company implemented the 2001 Employee Stock Purchase Plan (the “Purchase Plan”) with shareholder approval, effective January 1, 2001.  Under the Purchase Plan, employees meeting certain specific employment qualifications are eligible to participate and can purchase shares of common stock semi-annually through payroll deductions at the lower of 85% of the fair market value of the stock at the commencement or end of the offering period.  The purchase plan permits eligible employees to purchase shares of common stock through payroll deductions for up to 10% of qualified compensation, subject to maximum purchases in any one fiscal year of 3,000 shares.

In fiscal 2015, the Company amended the Purchase Plan with shareholder approval to increase the aggregate number of shares of stock reserved for issuance or transfer under the Plan by an additional 300,000 shares so that the total number of shares of stock reserved for issuance or transfer under the Plan shall be 1,100,000 shares and to extend the expiration date of the Plan to December 31, 2025.  In fiscal 2018, the Company amended the Purchase Plan with shareholder approval to increase the aggregate number of shares of stock reserved for issuance or transfer under the Plan by an additional 300,000 shares so that the total number of shares of stock reserved for issuance or transfer under the Plan shall be 1,400,000 shares.

The Company has two offering periods in the Purchase Plan coinciding with the Company’s first two fiscal quarters and the last two fiscal quarters.  Actual shares are issued on the first business day of the subsequent offering period for the prior offering period payroll deductions.  The number of shares issued on January 4, 2021 (the first business day following the previous offering period) was 53,906.  As of April 3, 2021, there were 95,988 shares available for issuance under the Purchase Plan.

19

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts, unless otherwise indicated)

11. Share-Based Compensation (Continued)

Time-Based Restricted Stock Awards / Stock Subscription Receivable

From time-to-time the Company issues time-based restricted stock units.  These time-based restricted stock units typically include dividend accrual equivalents, which means that any dividends paid by the Company during the vesting period become due and payable after the vesting period assuming the grantee’s restricted stock unit fully vests.  Dividends for these grants are accrued on the dividend payment dates and included in accounts payable and accrued expenses on the accompanying condensed consolidated balance sheet.  As of April 3, 2021, there were no accrued dividends.  Dividends for time-based restricted stock units that ultimately do not vest are forfeited.

The following summarizes the activity in the time-based restricted stock units under the 2014 Plan during the thirteen week period ended April 3, 2021:

	Number of Time-Based Restricted Stock Units		Weighted Average Grant Date Fair Value per Share
Outstanding non-vested at January 2, 2021	709,805		$1.92
Granted	96,749		$2.80
Vested	(107,696	)	$2.21
Forfeited or expired	-		-
Outstanding non-vested at April 3, 2021	698,858		$2.00

Based on the closing price of the Company’s common stock of $3.75 per share on April 1, 2021 (the last trading day prior to April 3, 2021), the intrinsic value of the time-based non-vested restricted stock units at April 3, 2021 was approximately $2.6 million.  As of April 3, 2021, there was approximately $1.1 million of total unrecognized compensation cost related to time-based restricted stock units, which is expected to be recognized over the average weighted remaining vesting period of the restricted stock units.

In December 2020, the Company granted members of senior management one-time restricted stock awards of an aggregate of 250,000 shares in exchange for a stock subscription receivable.  The shares will be acquired by senior management through repayment of the stock subscription receivable over twelve months beginning in January 2021 and ending in December 2021.

During the thirteen week period ended April 3, 2021, the Company awarded 125,000 immediately vested share awards at an average price of $2.17.  During fiscal 2020, the Company awarded 100,092 immediately vested share awards at an average price of $1.33.

Performance Based Restricted Stock Units

From time-to-time the Company issues performance-based restricted stock awards to its executives.  Performance-based restricted stock awards are typically vested based on certain multi-year performance metrics as determined by the Board of Directors Compensation Committee. These performance-based restricted stock awards typically include dividend accrual equivalents, which means that any dividends paid by the Company during the vesting period become due and payable after the vesting period on any stock awards that actually vest, if any.  Dividends for these grants are accrued on the dividend payment dates and included in accounts payable and accrued expenses on the accompanying condensed consolidated balance sheet.  As of April 3, 2021, there were no accrued dividends for performance-based restricted stock units.  Dividends for performance-based restricted stock units that ultimately do not vest are forfeited.  

20

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts, unless otherwise indicated)

11. Share-Based Compensation (Continued)

Performance Based Restricted Stock Units (Continued)

To date, the Company has issued performance-based restricted stock units only under the 2014 Plan.  The following summarizes the activity in the performance-based restricted stock units during the thirteen week period ended April 3, 2021:

	Number of Performance-Based Restricted Stock Units	Weighted Average Grant Date Fair Value per Share
Outstanding non-vested at January 2, 2021	-	-
Granted	90,000	$3.26
Vested	-	-
Forfeited or expired	-	-
Outstanding non-vested at April 3, 2021	90,000	$3.26

As of April 3, 2021, there were 90,000 performance-based restricted stock units outstanding. The Company assesses at each reporting date whether achievement of any performance condition is probable and recognizes the expense when achievement of the performance condition becomes probable.  The Company will then recognize the appropriate expense cumulatively in the year performance becomes probable and recognize the remaining compensation cost over the remaining requisite service period. If at a later measurement date the Company determines that performance-based restricted stock awards deemed as likely to vest are deemed as unlikely to vest, the expense recognized will be reversed.

12. Treasury Stock Transactions

On January 13, 2021, the Company’s Board of Directors authorized a program to repurchase shares of the Company’s common stock constituting, in the aggregate, up to an amount not to exceed $7.5 million, consistent with the maximum limitation set forth by the Company’s revolving line of credit.  The program is designed to provide the Company with enhanced flexibility over the long term to optimize its capital structure.  Shares of the common stock may be repurchased in the open market or through negotiated transactions.  The program may be terminated or suspended at any time at the discretion of the Company.

During the thirteen week period ended April 3, 2021, the Company purchased 344,172 shares at an average price of $2.65 per share.  During the thirteen week period ended March 28, 2020, the Company did not purchase any shares.  As of April 3, 2021, the Company has $6.6 million available for future treasury stock purchases.

21

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts, unless otherwise indicated)

13.   New Accounting Standards and Updates from the Securities Exchange Commission (“SEC”)

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326). The new standard amends guidance on reporting credit losses for assets held at amortized cost basis and available-for-sale debt securities.  In February 2020, the FASB issued ASU 2020-02, Financial Instruments-Credit Losses (Topic 326) and Leases (Topic 842) - Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases (Topic 842), which amends the effective date of the original pronouncement for smaller reporting companies.  ASU 2016-13 and its amendments will be effective for the Company for interim and annual periods in fiscal years beginning after December 15, 2022.  The Company believes the adoption will modify the way the Company analyzes financial instruments, but it does not anticipate a material impact on results of operations. The Company is in the process of determining the effects the adoption will have on its condensed consolidated financial statements.

In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This standard only applies to contracts and other transactions that reference London Interbank Offered Rate (LIBOR) or another reference rate expected to be discontinued due to reference rate reform.  This guidance provides temporary optional expedients and exceptions to accounting guidance on contract modifications and hedge accounting to ease entities’ financial reporting burdens as the market transitions from the LIBOR and other interbank offered rates to alternative reference rates. The Company may elect to apply the amendments prospectively through December 31, 2022.  The Company is currently evaluating the impact this guidance will have on its condensed consolidated financial statements and related disclosures.

22

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts, unless otherwise indicated)

14. Segment Information

The Company follows ASC280, “Segment Reporting,” which establishes standards for companies to report information about operating segments, geographic areas and major customers.  The accounting policies of each reportable segment are the same as those described in the summary of significant accounting policies (see Note 1 to the Company’s Condensed Consolidated Financial Statements included in its Annual Report on Form 10-K for the year ended January 2, 2021).

Segment operating income (loss) includes selling, general and administrative expenses directly attributable to that segment as well as charges for allocating corporate costs to each of the operating segments.  The following tables reflect the results of the reportable segments consistent with the Company’s management system:

Thirteen Week Period Ended April 3, 2021	Engineering		Specialty Health Care	Information Technology	Corporate		Total
Revenue	$14,466		$21,137	$8,946	$   -		$44,549
Cost of services	11,260		16,099	6,340	-		33,699
Gross profit	3,206		5,038	2,606	-		10,850
Selling, general and administrative	3,074		4,064	1,931	-		9,069
Depreciation and amortization of    property and equipment	156		82	28	-		266
Amortization of acquired intangible    assets	80		-	-	-		80
Tax credit professional fees	-		-	-	60		60
Operating income (loss)	($104	)	$892	$647	($60	)	$1,375
Total assets as of April 3, 2021	$35,898		$26,111	$8,385	$7,376		$77,770
Capital expenditures	$9		$28	$6	$4		$47

Thirteen Week Period Ended March 28, 2020	Engineering		Specialty Health Care		Information Technology	Corporate	Total
Revenue	$14,163		$22,197		$8,673	$   -	$45,033
Cost of services	10,205		17,812		6,173	-	34,190
Gross profit	3,958		4,385		2,500	-	10,843
Selling, general and administrative	3,424		4,400		2,413	-	10,237
Depreciation and amortization	238		77		20	-	335
Write-off of receivables related to    arbitration	8,047		-		-	-	8,047
Operating income (loss)	($7,751	)	($92	)	$67	$   -	($7,776	)
Total assets as of March 28, 2020	$43,690		$25,499		$8,717	$6,045	$83,951
Capital expenditures	$9		$10		$15	$1	$35

23

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts, unless otherwise indicated)

14. Segment Information (Continued)

The Company derives a majority of its revenue from offices in the United States.  Revenue reported for each operating segment are all from external customers.  The Company is domiciled in the United States and its segments operate in the United States, Canada, Puerto Rico and Serbia. Revenue by geographic area for the thirteen week periods ended April 3, 2021 and March 28, 2020 are as follows:

		Thirteen Week Periods Ended
		April 3, 2021	March 28, 2020
Revenue
	U. S.	$39,007	$39,176
	Canada	3,385	4,002
	Puerto Rico	1,515	1,202
	Serbia	642	653
		$44,549	$45,033

Total assets by geographic area as of the reported periods are as follows:

		April 3, 2021	January 2, 2021
Total assets
	U. S.	$64,680	$56,308
	Canada	7,720	7,067
	Puerto Rico	1,669	1,483
	Serbia	3,701	3,481
		$77,770	$68,339

15. Income Taxes

The Company recognized $0.4 million of income tax expense for the thirteen week period ended April 3, 2021, as compared to $2.2 million of income tax benefit for the comparable prior year period.  The consolidated effective income tax rate for the current period was 26.1% as compared to 27.4% for the comparable prior year period.  The projected fiscal 2021 income tax rates as of April 3, 2021, were approximately 28.0%, 26.5% and 15.1% in the United States, Canada and Serbia, respectively. The relative income or loss generated in each jurisdiction can materially impact the overall effective income tax rate of the Company, particularly the ratio of Canadian and Serbian pretax income versus U.S. pretax income.  The comparable prior year period estimated income tax rates were 27.0%, 28.1% and 15.5% in the United States, Canada and Serbia, respectively. 

Differences between the effective tax rate and the applicable U.S. federal statutory rate may arise, primarily from the effect of state and local income taxes, share-based compensation, and potential tax credits available to the Company. The actual 2021 effective tax rate may vary from the estimate depending on the actual operating income earned in various jurisdictions, the potential availability of tax credits, and the exercise of stock options and vesting of share-based awards. The Company's estimate for the 2021 effective tax rate has not been adjusted for any potential impact related to COVID-19.

24

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts, unless otherwise indicated)

16. Contingencies

From time to time, the Company is a defendant or plaintiff in various legal actions that arise in the ordinary business course.  These matters may relate to professional liability, tax, compensation, contract, competitor disputes, and employee-related matters and include individual and class action lawsuits, as well as inquiries and investigations by governmental agencies regarding the Company’s employment and compensation practices. Additionally, some of the Company’s clients may also become subject to claims, governmental inquiries and investigations, and legal actions relating to the Company’s professional services. Depending upon the particular facts and circumstances, the Company may also be subject to indemnification obligations under its contracts with such clients relating to these matters.

As such, the Company is required to assess the likelihood of any adverse outcomes to these matters as well as potential ranges of losses and possible recoveries.  The Company may not be covered by insurance as it pertains to some or all of these matters.  A determination of the amount of the provision required for these commitments and contingencies, if any, which would be charged to earnings, is made after careful analysis of each matter.  The Company records a liability when management believes an adverse outcome from a loss contingency is both probable and the amount, or a range, can be reasonably estimated. Significant judgment is required to determine both probability of loss and the estimated amount. The Company reviews its loss contingencies at least quarterly and adjusts its accruals and/or disclosures to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, or other new information, as deemed necessary. Once established, a provision may change in the future due to new developments or changes in circumstances and could increase or decrease the Company’s earnings in the period that the changes are made. 

The Company is exposed to various asserted claims as of April 3, 2021, where the Company believes it has a probability of loss. As of April 3, 2021, the Company has accrued $1.8 million for asserted claims of $2.0 million.  Additionally, the Company is exposed to other asserted claims whereby an amount of loss has not been declared, and the Company can’t determine the potential loss. Any of these various claims could result in an unfavorable outcome or settlement that exceeds the accrued amounts. However, the Company believes that such matters will not, either individually or in the aggregate, have a material adverse effect on its business, consolidated financial position, results of operations, or cash flows. Included in the April 3. 2021 accrual of $1.8 million, the Company has reserved $1.7 million for the settlement of a class-action suit in California that alleges the Company did not properly pay its travel nurses overtime wages. While the Company believes it did not violate any overtime wage laws, it nevertheless decided to settle this class action lawsuit in December 2020.  The Company expects to pay the $1.7 million settlement sometime during the third quarter of fiscal 2021.

25

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts, unless otherwise indicated)

17. Leases

Leases are recorded in accordance with FASB ASC 842, Leases which requires lessees to recognize a right-of-use (“ROU”) asset and an operating right of use liability for all leases with terms greater than 12 months and requires disclosures by lessees and lessors about the amount, timing and uncertainty of cash flows arising from leases.

The Company determines if an arrangement is a lease at inception. For leases where the Company is the lessee, right of use assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. Right of use assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. The right of use asset also consists of any lease incentives received. The lease terms used to calculate the right of use asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as depreciation expense and interest expense using the accelerated interest method of recognition. The Company has lease agreements which require payments for lease and non-lease components.  The Company has elected to account for these as a single lease component with the exception of its real estate leases.

The components of lease expense were as follows:

		Thirteen Week Periods Ended
		April 3, 2021	March 28, 2020
Operating lease cost		$537	$656
	Amortization of right of use assets	$91	$78
	Interest on lease liabilities	$2	$2
Total finance lease cost		$93	$80

Supplemental Cash Flow information related to leases was as follows:

		Thirteen Week Period Ended
		April 3, 2021	March 28, 2020
Cash paid for amounts included in the measurement    of lease liabilities
	Operating cash flows from operating leases	$552	$663
	Operating cash flows from finance leases	$1	$2
	Financing cash flows from finance leases	$74	$80
Right of use assets obtained in exchange for lease    obligations
	Operating leases	$145	$250
	Finance leases	-	-

26

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts, unless otherwise indicated)

17. Leases (Continued)

Supplemental Balance Sheet information as of April 3, 2021 and January 2, 2021 related to leases was as follows:

		April 3, 2021		January 2, 2021
Operating leases
	Operating lease right of use assets	$2,263		$2,409
	Operating right of use liability - current	($1,937	)	($1,886	)
	Operating right of use liability - non-current	(2,224	)	(2,641	)
	Total operating lease liabilities	($4,161	)	($4,527	)
	Property and equipment - (right of use assets)	$1,140		$1,140
	Accumulated depreciation	(837	)	(746	)
	Property and equipment, net	$303		$394
	Finance lease liability - current	($183	)	($247	)
	Finance lease liability - non-current	(96	)	(106	)
	Total finance lease liabilities	($279	)	($353	)
Weighted average remaining lease term
	Operating leases	1.36 Years		2.03 Years
	Finance leases	1.43 Years		1.45 Years
Weighted average discount rate
	Operating leases	3.08	%	4.06	%
	Finance leases	2.88	%	2.63	%

Maturities of lease liabilities are as follows:

Fiscal Year	Operating Leases		Finance Leases
2021 (after April 3, 2021)	$1,574		$180
2022	1,532		108
2023	967		-
2024	233		-
2025	48		-
Total lease payments	4,354		288
Less: imputed interest	(193	)	(9	)
Total	$4,161		$279

27

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts, unless otherwise indicated)

18.  Stockholder Rights Plan

On May 22, 2020, the Board of Directors of the Company approved a stockholder rights plan (the “Rights Plan”) and declared a dividend distribution to stockholders of record as of the close of business on June 2, 2020 of onepreferred stock purchase right (a“Right”) for each outstanding share of Common Stock of the Company.Each Right entitles the holder to purchase from the Company a unit consisting of one one-hundredth of a share (a “Unit”) of a newly-authorized series of junior participating preferred stock of the Company, upon the occurrence of certain events, as more fully described below, at a purchase price of $5.60 per Unit.

In connection with the adoption of the stockholder rights plan, the Company designated 250,000 shares of the Company’s authorized shares of Preferred Stock, par value $1.00, as Series A-3 Junior Participating Preferred Shares, none of which are issued and outstanding. As provided in the Certificate of Designation filed by the Company with the Department of State of the State of Nevada, each Series A-3 Preferred Share shall entitle the holder 100 votes on all matters submitted to a vote of the stockholders of the Company, subject to adjustment for future dividends and combinations of common stock.  The holders of Series A-3 Preferred Shares and the holders of shares of Common Stock shall vote together as one class on all matters submitted to a vote of stockholders of the Company.  The Series A-3 Preferred Shares shall, after issuance, be entitled to receive quarterly dividends in an amount equal to the greater of $50.00 per share or an amount per share, subject to adjustment, equal to 100 times the aggregate per share amount of all non-cash dividends or other distributions other than a dividend payable in shares of common stock or a subdivision of the outstanding shares of common stock declared on the common stock since the immediately preceding quarterly dividend payment date of the Series A-3 Preferred Shares, or, with respect to the first such quarterly dividend payment date, since the first issuance of any share or fraction of a share of the Series A-3 Preferred Shares.  The Series A-3 Preferred Shares shall rank junior to all other series of the Company’s Preferred Stock as to the payment of dividends and the distribution of assets, unless the terms of any such series shall provide otherwise.  The Series A-3 Preferred Shares shall not be redeemable.  In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company, the holders of Series A-3 Preferred Shares shall be entitled to receive the greater of $100.00 per share, plus accrued dividends, or an amount per share, subject to adjustment, equal to 100 times the aggregate amount to be distributed per share to holders of Common Stock. In the event the Company shall enter into any consolidation, merger, combination or other transaction in which the shares of Common Stock are exchanged for or changed into other stock or securities, cash and/or any other property, then in any such event the Series A-3 Preferred Shares shall at the same time be similarly exchanged or changed in an amount per share, subject to adjustment, equal to 100 times the aggregate amount of stock, securities, cash and/or any other property (payable in kind), as the case may be, into which or for which each share of Common Stock is changed or exchanged. These preferences are protected by customary anti-dilution provisions.

Initially, the Rights are not exercisable and are attached to each existing outstanding share of the Company’s Common Stock. The Rightswill separate and become exercisable if a person or group acquires 10% or more of the Company’s Common Stock in a transaction, including the open market purchase of shares, not approved by our Board. If a person or group acquires 10%, each Right will entitle its holder (other than such person or members of such group) to purchase, at the Right’s exercise price (subject to adjustment as provided in the Rights Plan), a number of shares of the Company’s Common Stock having a then-current market value of twice the exercise price.The Rights Plan will cause substantial dilution to a person or group that attempts to acquire control of the Company on terms or in a manner not approved by our Board.

28

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts, unless otherwise indicated)

18.  Stockholder Rights Plan (Continued)

The initial issuance of the Rights as a dividend had no financial accounting or reporting impact. The fair value of the Rights was nominal because the Rights were not exercisable when issued and no value is attributable to them. Additionally, the Rights do not meet the definition of a liability under generally accepted accounting principles in the United States and are therefore not accounted for as a long-term obligation.  Accordingly, unless the Rights become exercisable as discussed above, the Rights Plan has no impact on the Company’s Condensed Consolidated Financial Statements.

The Company’s Board of Directors may redeem the Rights for $0.001 per Right at any time before an event that causes the Rights to become exercisable. The Rights will expire on May 22, 2021, unless the Rights have previously been redeemed by the Board of Directors.

The Rights Plan is not intended to interfere with any merger, tender or exchange offer or other business combination approved byour Board.  Nor does the Rights Plan prevent ourBoard from considering any offer that it considers to be in the best interest of its stockholders.

19.   COVID-19

In March 2020, the World Health Organization declared the outbreak of a novel coronavirus (COVID-19) as a pandemic, which continues to present various health, business and other challenges throughout the United States. As a result, we have temporarily closed most of our office locations, with most of our workforce working from home, and have seen a reduction in customer demand, all resulting in a negative impact on Company revenue, gross profit, and operating income. The duration and ultimate magnitude of the disruption remains uncertain. Therefore, while we experienced a negative impact during fiscal 2020 and our first quarter of fiscal 2021, we expect this matter to continue to negatively impact our business, results of operations, and financial position throughout fiscal 2021 and possibly beyond, and the related financial impact cannot be reasonably estimated at this time.

29

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Private Securities Litigation Reform Act Safe Harbor Statement

Certain statements included herein and in other reports and public filings made by RCM Technologies, Inc. (“RCM” or the “Company”) are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995.  These forward-looking statements include, without limitation, statements regarding the adoption by businesses of new technology solutions; the use by businesses of outsourced solutions, such as those offered by the Company, in connection with such adoption; the Company’s strategic and business initiatives and growth strategies; and the outcome of litigation (at both the trial and appellate levels) and arbitrations, or other business disputes, involving the Company.  Readers are cautioned that such forward-looking statements, as well as others made by the Company, which may be identified by words such as “may,” “will,” “expect,” “anticipate,” “continue,” “estimate,” “project,” “intend,” “believe,” and similar expressions, are only predictions and are subject to risks and uncertainties that could cause the Company’s actual results and financial position to differ materially from such statements.  Such risks and uncertainties include, without limitation:  (i) unemployment and general economic conditions affecting the provision of information technology and engineering services and solutions and the placement of temporary staffing personnel; (ii) the effects of the COVID-19 pandemic; (iii) the Company’s ability to continue to attract, train and retain personnel qualified to meet the requirements of its clients; (iv) the Company’s ability to identify appropriate acquisition candidates, complete such acquisitions and successfully integrate acquired businesses; (v) the Company’s relationships with and reliance upon significant customers, and ability to collect accounts receivable from such customers; (vi) risks associated with foreign currency fluctuations and changes in exchange rates, particularly with respect to the Canadian dollar; (vii) uncertainties regarding amounts of deferred consideration and earnout payments to become payable to former shareholders of acquired businesses; (viii) the adverse effect a potential decrease in the trading price of the Company’s common stock would have upon the Company’s ability to acquire businesses through the issuance of its securities; (ix) the Company’s ability to obtain financing on satisfactory terms; (x) the reliance of the Company upon the continued service of its executive officers; (xi) the Company’s ability to remain competitive in the markets that it serves; (xii) the Company’s ability to maintain its unemployment insurance premiums and workers compensation premiums; (xiii) the risk of claims being made against the Company associated with providing temporary staffing services; (xiv) the Company’s ability to manage significant amounts of information and periodically expand and upgrade its information processing capabilities; (xv) the risk of cyber attacks on our information technology systems or those of our third party vendors; (xvi) the Company’s ability to remain in compliance with federal and state wage and hour laws and regulations; (xvii) uncertainties in predictions as to the future need for the Company’s services; (xviii) uncertainties relating to the allocation of costs and expenses to each of the Company’s operating segments; (ixx) the costs of conducting and the outcome of litigation, arbitrations and other business disputes involving the Company, and the applicability of insurance coverage with respect to any such litigation; (xx) the results of, and costs relating to, any interactions with shareholders of the Company who may pursue specific initiatives with respect to the Company’s governance and strategic direction, including without limitation a contested proxy solicitation initiated by such shareholders, or any similar such interactions; and (xxi) other economic, competitive, health and governmental factors affecting the Company’s operations, markets, products and services.  Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made.  Except as required by law, the Company undertakes no obligation to publicly release the results of any revision of these forward-looking statements to reflect these trends or circumstances after the date they are made or to reflect the occurrence of unanticipated events.

30

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

COVID-19 Considerations

The Company’s priorities during the COVID-19 pandemic are protecting the health and safety of our employees and, especially in the healthcare segment, deploying our resources, including the talents of our employees, to help the communities we serve meet and overcome the current challenges. In the future, the pandemic may continue to cause reduced demand for our services if, for example, the pandemic results in a prolonged recessionary economic environment affecting industries in which we serve; however, since certain services that we offer are essential to the daily lives of our customers, we believe that over the long term, there will continue to be demand for our services. 

Our ability to continue to operate without any significant negative operational impact from the COVID-19 pandemic will in part depend on our ability to protect our employees and our supply chain. The Company has endeavored to follow the recommended actions of government and health authorities to protect our employees, with particular measures in place for those working in our customer facilities. For the thirteen week period ended April 3, 2021, while our revenue, gross profit and operating income were negatively impacted, we maintained the consistency of our operations, to a substantial degree, during the onset of the COVID-19 pandemic. We intend to continue to adhere to our employee safety measures as we seek to ensure that any disruptions to our operations remain as limited as possible during the pandemic. However, the uncertainty resulting from the pandemic could result in an unforeseen disruption to our workforce and supply chain (for example, an inability of a key supplier or transportation supplier to source and transport materials) that could negatively impact our operations. 

For additional information on risk factors related to the pandemic or other risks that could impact our results, please refer to “Risk Factors” in Part II, Item 1A of this Form 10-Q. For additional information on how COVID-19 has impacted operations and our financial position, please refer to the Segment Discussion and Liquidity and Capital Resources sections in Management’s Discussion and Analysis of Financial Condition and Results of Operations.

31

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (CONTINUED)

Overview

RCM participates in a market that is cyclical in nature and sensitive to economic changes.  As a result, the impact of economic changes on revenue and operations can be substantial, resulting in significant volatility in the Company’s financial performance.

In March 2020, the World Health Organization declared the outbreak of a novel coronavirus (COVID-19) as a pandemic, which continues to present various health, business and other challenges throughout the United States. As a result, we have temporarily closed most of our office locations, with most of our workforce working from home, and have seen a reduction in customer demand, all resulting in a negative impact on Company revenue, gross profit and operating income. The duration and ultimate magnitude of the disruption remains uncertain. We experienced a negative impact in fiscal 2020 and we expect the pandemic and its effects to negatively impact our business, results of operations, and financial position also through at least the first half of fiscal 2021 and likely beyond.  The related financial impact cannot be reasonably estimated at this time. Please see more detailed disclosure by segment in our Segment Discussion and the impact to our consolidated financial position under Financial Activities under Liquidity and Capital Resources, all in Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The Company believes it has developed and assembled an attractive portfolio of capabilities, established a proven record of performance and credibility and built an efficient pricing structure.  The Company is committed to optimizing its business model as a single-source premier provider of business and technology solutions with a strong vertical focus offering an integrated suite of services through a global delivery platform.

The Company believes that most companies recognize the importance of advanced technologies and business processes to compete in today’s business climate.  However, the process of designing, developing and implementing business and technology solutions is becoming increasingly complex.  The Company believes that many businesses today are focused on return on investment analysis in prioritizing their initiatives.  This has had an adverse impact on spending by current and prospective clients for many emerging new solutions.

Nonetheless, the Company continues to believe that businesses must implement more advanced information technology and engineering solutions to upgrade their systems, applications and processes so that they can maximize their productivity and optimize their performance in order to maintain a competitive advantage.  Although working under budgetary, personnel and expertise constraints, companies are driven to support increasingly complex systems, applications and processes of significant strategic value.  This has given rise to a demand for outsourcing.  The Company believes that its current and prospective clients are continuing to evaluate the potential for outsourcing business critical systems, applications and processes.

The Company provides project management and consulting services, which are billed based on either agreed-upon fixed fees or hourly rates, or a combination of both.  The billing rates and profit margins for project management and solutions services are generally higher than those for professional consulting services.  The Company generally endeavors to expand its sales of higher margin solutions and project management services.  The Company also realizes revenue from client engagements that range from the placement of contract and temporary technical consultants to project assignments that entail the delivery of end-to-end solutions.  These services are primarily provided to the client at hourly rates that are established for each of the Company’s consultants based upon their skill level, experience and the type of work performed.

The majority of the Company’s services are provided under purchase orders.  Contracts are utilized on certain of the more complex assignments where the engagements are for longer terms or where precise documentation on the nature and scope of the assignment is necessary.  Although contracts normally relate to longer-term and more complex engagements, they do not obligate the customer to purchase a minimum level of services and are generally terminable by the customer on 60 to 90 days’ notice.  The Company, from time to time, enters into contracts requiring the completion of specific deliverables.  Typically these contracts are for less than one year.  The Company recognizes revenue on these deliverables at the time the client accepts and approves the deliverables.

32

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (CONTINUED)

Overview (Continued)

Costs of services consist primarily of salaries and compensation-related expenses for billable consultants and employees, including payroll taxes, employee benefits and insurance.  Selling, general and administrative expenses consist primarily of salaries and benefits of personnel responsible for business development, recruiting, operating activities, and training, and include corporate overhead expenses.  Corporate overhead expenses relate to salaries and benefits of personnel responsible for corporate activities, including the Company’s corporate marketing, administrative and financial reporting responsibilities and acquisition program.  The Company records these expenses when incurred.  Corporate overhead expenses are allocated to the segments based on revenue for the purpose of segment financial reporting.

Critical Accounting Policies and Use of Estimates

This Management's Discussion and Analysis of Financial Condition and Results of Operations is based on our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenue and expenses during the reporting period. In our consolidated financial statements, estimates are used for, but not limited to, accounts receivable and allowance for doubtful accounts, goodwill, long-lived intangible assets, accounting for stock options and restricted stock awards, insurance liabilities, accounting for income taxes and accrued bonuses.

A summary of our significant accounting policies is included in our Consolidated Financial Statements, Note 1, Summary of Significant Accounting Policies, in our Annual Report on Form 10-K for the year ended January 2, 2021. Certain of our accounting policies are considered critical, as these policies require significant, difficult or complex judgments by management, often requiring the use of estimates about the effects of matters that are inherently uncertain. Such policies are summarized in Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report on Form 10-K for the year ended January 2, 2021.

Recently Issued Accounting Pronouncements

A discussion of the recently issued accounting pronouncements is set forth in Note 13, New Accounting Standards, in the unaudited condensed consolidated financial statements included in Part I, Item I of this Quarterly Report on Form 10-Q and is incorporated herein by reference.

Forward-looking Information

The Company’s growth prospects are influenced by broad economic trends.  The pace of customer capital spending programs, new product launches and similar activities have a direct impact on the need for engineering and information technology services.  When the U.S., Canadian or global economies decline, the Company’s operating performance could be adversely impacted.  In addition, global events such as the ongoing COVID-19 pandemic also have a substantial impact on our operations and financial results.  The Company believes that its fiscal discipline, strategic focus on targeted vertical markets and diversification of service offerings provides some insulation from adverse trends.  However, general economic declines could result in the need for future cost reductions or changes in strategy.

Additionally, changes in government regulations could result in prohibition or restriction of certain types of employment services or the imposition of new or additional employee benefits, licensing or tax requirements with respect to the provision of employment services that may reduce the Company’s future earnings.  There can be no assurance that the Company will be able to increase the fees charged to its clients in a timely manner and in a sufficient amount to cover increased costs as a result of any of the foregoing.

33

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (CONTINUED)

Forward-looking Information (Continued)

The consulting and employment services market is highly competitive with limited barriers to entry.  The Company competes in global, national, regional and local markets with numerous competitors in all of the Company’s service lines.  Price competition in the industries the Company serves is significant, and pricing pressures from competitors and customers are increasing.  The Company expects that the level of competition will remain high in the future, which could limit the Company’s ability to maintain or increase its market share or profitability.

Thirteen Week Period Ended April 3, 2021 Compared to Thirteen Week Period Ended March 28, 2020

A summary of operating results for the thirteen week periods ended April 3, 2021 and March 28, 2020 is as follows (in thousands):

	April 3, 2021		March 28, 2020
	Amount	% of Revenue	Amount		% of Revenue
Revenue	$44,549	100.0	$45,033		100.0
Cost of services	33,699	75.6	34,190		75.9
Gross profit	10,850	24.4	10,843		24.1
Selling, general and administrative	9,069	20.4	10,237		22.7
Depreciation and amortization of property and equipment	266	0.6	255		0.6
Amortization of acquired intangible assets	80	0.2	80		0.2
Write-off of receivables and professional fees    incurred related to arbitration	-	0.0	8,047		17.9
Tax credit professional fees	60	0.1	-		0.0
	9,475	21.3	18,619		41.4
Operating income (loss)	1,375	3.1	(7,776	)	(17.3	)
Other expense, net	12	0.0	409		0.9
Income (loss) before income taxes	1,363	3.1	(8,185	)	(18.2	)
Income tax expense (benefit)	356	0.8	(2,240	)	(5.0	)
Net income (loss)	$1,007	2.3	($5,945	)	(13.2	)

The Company follows a 52/53 week fiscal reporting calendar ending on the Saturday closest to December 31.  The fiscal quarters ended April 3, 2021 and March 28, 2020 consisted of thirteen weeks each.

Revenue.  Revenue decreased 1.1%, or $0.5 million, for the thirteen week period ended April 3, 2021 as compared to the thirteen week period ended March 28, 2020 (the “comparable prior year period”).  Revenue increased $0.3 million in the Engineering segment, decreased $1.1 million in the Specialty Health Care segment and increased $0.3 million in the Information Technology segment.  See more detailed disclosure by segment in our Segment Discussion.

34

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (CONTINUED)

Thirteen Week Period Ended April 3, 2021 Compared to Thirteen Week Period Ended March 28, 2020 (Continued)

Cost of Services and Gross Profit.  Cost of services decreased 1.4%, or $0.5 million, for the thirteen week period ended April 3, 2021 as compared to the comparable prior year period. Cost of services decreased primarily due to the decrease in revenue.  Cost of services as a percentage of revenue for the thirteen week periods ended April 3, 2021 and March 28, 2020 was 75.6% and 75.9%, respectively.  See Segment Discussion for further information regarding changes in cost of services and gross profit.

Selling, General and Administrative.  Selling, general and administrative (“SGA”) expenses were $9.1 million for the thirteen week period ended April 3, 2021 as compared to $10.2 million for the comparable prior year period.  As a percentage of revenue, SGA expenses were 20.4% for the thirteen week period ended April 3, 2021 and 22.7% for the comparable prior year period.   See Segment Discussion for further information on SGA expense changes.

Write-off of receivables related to arbitration. The Company recorded an impairment charge of $8.0 million during the quarter ended March 28, 2020 relating to its dispute with a customer that is a major utility in the United States, which was resolved through binding arbitration, which concluded in April 2020.  The charge consisted of $6.7 million constituting the portion of accounts receivable previously recognized by the Company that was not awarded by the arbitrator, $0.7 million from other projects with this customer that were not part of the arbitration, $0.4 million in professional fees related to the dispute and arbitration and $0.2 million of transit accounts receivable associated with disputed projects that were part of the arbitration. The Company decided to write off the $0.7 million of accounts receivable from other projects not part of the arbitration for business reasons.  For the thirteen week period ended April 3, 2021, there were no such impairment charges. See discussion of Contingencies in Note 16 to the Condensed Consolidated Financial Statements included in this report.

Tax Credit Professional Fees. The Company incurred $0.1 million in tax credit professional fees in the thirteen week period ended April 3, 2021 as compared to $0 tax credit professional fees in the comparable prior year period.

Other Expense.  Other expense consists of interest expense, unused line fees and amortized loan costs on the Company’s line of credit, net of interest income, imputed interest on contingent consideration and gains and losses on foreign currency transactions.  Other expense, net decreased by $0.4 million as compared to the comparable prior year period.  The primary component of the decrease related to interest expense, which decreased primarily due to a decreased average borrowing and a decreased borrowing rate under the Company’s line of credit.  The primary reason for the decreased average borrowing rate was change in macroeconomic borrowing rates. 

Income Tax Expense (Benefit).  The Company recognized $0.4 million of income tax expense for the thirteen week period ended April 3, 2021, as compared to $2.2 million of income tax benefit for the comparable prior year period.  The consolidated effective income tax rate for the current period was 26.1% as compared to 27.4% for the comparable prior year period.  The projected fiscal 2021 income tax rates as of April 3, 2021, were approximately 28.0%, 26.5% and 15.1% in the United States, Canada, and Serbia, respectively. The relative income or loss generated in each jurisdiction can materially impact the overall effective income tax rate of the Company, particularly the ratio of Canadian and Serbian pretax income versus U.S. pretax income. 

Differences between the effective tax rate and the applicable U.S. federal statutory rate may arise, primarily from the effect of state and local income taxes, share-based compensation, and potential tax credits available to the Company. The actual 2021 effective tax rate may vary from the estimate depending on the actual operating income earned in various jurisdictions, the potential availability of tax credits, and the exercise of stock options and vesting of share-based awards. The Company's estimate for the 2021 effective tax rate has not been adjusted for any potential unknown impact related to COVID-19.

35

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (CONTINUED)

Thirteen Week Period Ended April 3, 2021 Compared to Thirteen Week Period Ended March 28, 2020 (Continued)

Segment Discussion

Engineering

Engineering revenues of $14.5 million for the thirteen weeks ended April 3, 2021 increased 2.1%, or $0.3 million, compared to the comparable prior year period.  The increase was comprised of the following: an increase in Aerospace revenue of $1.1 million, a decrease in the Canadian Power Systems Group revenue of $0.7 million, a decrease in Energy Services revenue of $0.8 million, and an increase in Industrial Processing revenue of $0.7 million.  The increase in Aerospace revenue was primarily due to a new outsourcing engagement with one of the Company’s major customers that is anticipated to become a multi-year contract. The decreases in the Canadian Power Systems and Energy Services revenue were primarily due to spending decreases with several major customers and the impact of COVID-19. The increase in Industrial Processing revenue was primarily due to spending increases with several major customers seeking to upgrade their ethanol related production capability. Gross profit decreased by 19.0%, or $0.8 million, as compared to the comparable prior year period. Gross profit decreased primarily because of the decrease in gross profit margin. Gross profit margin of 22.2% for the current period decreased from 27.9% for the comparable prior year period. The decrease in gross margin was primarily due to decreased revenue from the Canadian Power Systems and Energy Services groups, as lower revenue has negatively impacted utilization of the Engineering segment’s billable consultants.  Additionally, the new Aerospace contract will garner a lower gross margin than the Engineering segment typically experiences. The Engineering segment’s SGA expense of $3.1 million decreased by $0.3 million due to concerted effort to reduce SGA expense and gain efficiency on current SGA expenses. The Engineering segment experienced an operating loss of $0.1 million for the thirteen week period ended April 3, 2021, as compared to a $7.8 million operating loss for the comparable prior year period. The primary reason for the operating loss in the comparable prior year period was the $8.0 million write-off of receivables and professional fees incurred related to a discrete arbitration.

COVID-19 Impact to Engineering Segment

It is difficult to assess both the current and future impact from COVID-19 to the Engineering segment, due to the high degree of uncertainty around COVID-19 and the duration and extent of the pandemic. The Engineering segment has seen a decline in its field services work as its personnel has limited access to client facilities. It is difficult to determine the impact on revenue from the loss in field services work. The Company believes that an undetermined amount of field services work will eventually return as a portion of that work is mission-critical to our clients. However, given the uncertainties around COVID-19, the Company can give no assurances that it will see an increase in field services revenue.  Additionally, the Company believes that COVID-19 has had a significant adverse impact on the budgets of many of its Aerospace and Utilities clients.  The Company’s Aerospace clients have seen an impact to their commercial lines of business.  A number of the Company’s Utility clients have been impacted by their customers’ inability to pay their monthly electric bills.

The Company has transitioned most of its Engineering workforce to work from home. While this has constituted a significant effort, particularly from a technology standpoint, the Company believes that this effort has been completed relatively effectively. The Company also believes that its Engineering clients have been generally supportive of these efforts and believes further that it has not lost any significant, previously awarded work. The Engineering segment continues to see new work proposals, but not at the same level as seen prior to COVID-19. The Engineering segment’s general response to the effects of COVID-19 is to continue to focus on maximizing gross margin by focusing on utilization of billable consultants and maximizing the efficiency of its SGA expense.  The Company plans to refine its strategy for responding to COVID-19 as necessary as the situation develops.

36

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (CONTINUED)

Thirteen Week Period Ended April 3, 2021 Compared to Thirteen Week Period Ended March 28, 2020 (Continued)

Segment Discussion (Continued)

Specialty Health Care

Specialty Health Care revenue of $21.1 million for the thirteen week period ended April 3, 2021 decreased 4.8%, or $1.1 million, as compared to the comparable prior year period.  The decrease in revenue was primarily driven by school closures related to COVID-19 (see below). The Specialty Health Care segment’s gross profit increased by 14.9%, or $0.6 million, to $5.0 million for the thirteen week period ended April 3, 2021, as compared to $4.4 million for the prior year period. The increase in gross profit was driven by higher gross profit margin. Gross profit margin for the thirteen week period ended April 3, 2021 increased to 23.8% as compared to 19.8% for the comparable prior year period. The increase in gross profit margin was primarily due to an increase in non-school revenue at a higher gross margin and a decrease in severance paid to billable personnel in the current period. Specialty Health Care experienced operating income of $0.9 million for the thirteen week period ended April 3, 2021, as compared to an operating loss of $0.1 million for the comparable prior year period. The primary reason for the increase in operating income was the increase to gross profit, and also a decrease in SGA expense. SGA expense decreased by $0.3 million to $4.1 million, as compared to $4.4 million in the comparable prior year period. The decrease in SGA expense was primarily due to a concerted effort to reduce SGA expense in response to the impact of COVID-19 on school services revenue, and a desire to gain greater efficiency from SGA expense.

COVID-19 Impact to Specialty Health Care Segment

It is difficult to assess both the current and future impact from COVID-19 to the Specialty Health Care segment, due to the high degree of uncertainty around COVID-19 and the duration and extent of the pandemic, especially as it may impact schools where many of our personnel work. While the Company has worked to transition a portion of its Specialty Health Care workforce to work from home, this has been a difficult task. The Specialty Health Care segment has a small number of billable professionals performing services from home, in particular telehealth services. The Specialty Health Care segment’s telehealth services are primarily a new service offering. The majority of the Specialty Health Care segment’s services are historically delivered at schools and health care facilities. The Company believes that demand for much of its non-school services is very high as a result of COVID-19. However, health care professionals, such as nurses and doctors, are scarce and difficult to recruit.  Furthermore, the demand for non-COVID-19 related healthcare services has been reduced as a result of the pandemic.

The Specialty Health Care Segment has historically derived much of its revenue from school systems. Many school systems nationwide, including most of the Company’s school clients, closed down for in-person instruction in March 2020. Most of our school clients have opened with a combination of in-person and virtual lessons, while some have remained primarily virtual.  The Company has limited information on when, and in what manner, they will reopen in a comparable manner as to how they operated before COVID-19. Many schools are under pressure by employee unions to limit in-person classes. Any announced plans are subject to rapid changes.

The Specialty Health Care's largest school clients are the New York City Department of Education, the Hawaii Department of Education, and the Chicago Public School System. There are numerous factors that could influence further decisions of these school systems on their operations. Any shift toward hybrid and remote operations can have a materially negative impact on revenue generated by the Specialty Healthcare segment.

The Specialty Health Care segment generated $13.3 million in revenue from schools for the thirteen week period ended April 3, 2021, as compared to $17.4 million for the comparable prior year period. It is difficult to estimate the impact of the school closures and reopenings on the Company’s fiscal 2021 and beyond.  At some point in the future, its school clients will return to a normalized level of operations. However, the Company can give no assurance of when or even if this normalization will occur.

37

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (CONTINUED)

Thirteen Week Period Ended April 3, 2021 Compared to Thirteen Week Period Ended March 28, 2020 (Continued)

Segment Discussion (Continued)

The Specialty Health Care segment continues to see new work proposals related to non-school related revenue streams. The Specialty Health Care segment’s general response to the effects of COVID-19 is to continue to focus on maximizing gross margin by focusing on utilization of billable personnel and maximizing the efficiency of its SGA expense. The Specialty Health Care segment has made significant reductions to its SGA cost structure.  The Company plans to refine its strategy for responding to COVID-19 as necessary as the situation develops.

Information Technology

Information Technology revenue of $8.9 million for the thirteen week period ended April 3, 2021 increased 3.1%, or $0.2 million, as compared to $8.7 million for the comparable prior year period. The increase in Information Technology was primarily driven by the Life Sciences practice. The Company believes that the Life Sciences industry has not seen a negative impact from COVID-19. Gross profit of $2.6 million for the thirteen week period ended April 3, 2021 increased 4.2%, or $0.1 million, as compared to $2.5 million for the comparable prior year period. The increase in gross profit was primarily due to the increase in revenue, but partially increased by an increase in gross profit margin.  The Information Technology gross profit margin for the thirteen week period ended April 3, 2021 was 29.1% as compared to 28.8% for the comparable prior year period.  The Company attributes the gross profit margin increase to higher revenue from its Life Sciences practice and a concerted effort to increase gross profit margin. SGA expense decreased by $0.5 million to $1.9 million, as compared to $2.4 million in the comparable prior year period. The decrease in SGA expense was a driven by a concerted effort to reduce SGA expense after the uncertainty around the COVID-19 crisis. The Information Technology segment experienced operating income of $0.6 million as compared to $0.1 million of operating income for the comparable prior year period.  The increase in operating income was primarily due to the increase in revenue and gross profit, and also the decrease in SGA expense.

It is difficult to assess both the current and future impact from COVID-19 to the Information Technology segment, due to the high degree of uncertainty around COVID-19 and the duration and extent of the pandemic. The Information Technology segment has seen a decline in its field services work as its personnel has limited access to client facilities. It is difficult to determine the impact on revenue from the loss in field services work.

COVID-19 Impact to Information Technology Segment

The Company has transitioned most of its Information Technology workforce to work from home. While this has constituted a significant effort, particularly from a technology standpoint, the Company believes that this effort has been completed relatively effectively. The Company also believes that its Information Technology clients have been generally supportive of these efforts and believes further that it has not lost any significant, previously awarded work. The Information Technology segment’s general response to the effects of COVID-19 is to continue to focus on maximizing gross margin by focusing on utilization of billable consultants and maximizing the efficiency of its SGA expense. The Company plans to refine its strategy for responding to COVID-19 as necessary as the situation develops.

38

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (CONTINUED)

Liquidity and Capital Resources

The following table summarizes the major captions from the Company’s Condensed Consolidated Statements of Cash Flows (in thousands):

		Thirteen Week Periods Ended
		April 3, 2021		March 28, 2020
Cash (used in) provided by:
	Operating activities	($9,190	)	$929
	Investing activities	($47	)	($35	)
	Financing activities	$9,315		($1,934	)

Operating Activities

Operating activities used $9.2 million of cash for the thirteen week period ended April 3, 2021 as compared to providing cash of $0.9 million in the comparable prior year period.  The major components of cash provided by or used in operating activities in the thirteen week period ended April 3, 2021 and the comparable prior year period are as follows: net loss or income and changes in accounts receivable, the net of transit accounts payable and transit accounts receivable, prepaid expenses and other current assets, accounts payable and accrued expenses and accrued payroll and related costs.

For the thirteen week period ended April 3, 2021, the Company experienced net income of $1.0 million as compared to a net loss of $5.9 million for the comparable prior year period.  An increase in accounts receivables in the thirteen week period ended April 3, 2021, exclusive of the impact of the arbitration resolution, used $9.1 million of cash as compared to providing cash of $1.0 million in the comparable prior year period. The Company primarily attributes this increase in accounts receivables for the thirteen week period ended April 3, 2021 to the increase in revenue for the thirteen week period ended April 3, 2021 as compared to the thirteen week period ended January 2, 2021 and certain customers with temporary administrative issues with approving invoices.

The Company’s transit accounts payable usually exceeds the Company’s transit accounts receivable, but absolute amounts and differences fluctuate significantly from quarter to quarter in the normal course of business.  The net of transit accounts payable and transit accounts receivable was a net payable of $0.6 million as of April 3, 2021 and a net payable of $2.4 million as of January 2, 2021, using $1.8 million of cash during the thirteen week period ended April 3, 2021.  The net of transit accounts payable and transit accounts receivable was a net payable of $0.6 million as of March 28, 2020 and a net receivable of $0.3 million as of December 28, 2019, generating $0.9 million of cash during the thirteen week period ended March 28, 2020. 

Prepaid expenses and other current assets provided cash of $0.6 million for the thirteen week period ended April 3, 2021 as compared to $0.2 million of cash for the comparable prior year period.  The Company attributes changes to prepaid expenses and other current assets, if any, to general timing of payments in the normal course of business.

A decrease in accounts payable and accrued expenses used cash of $0.6 million for the thirteen week period ended April 3, 2021 as compared to using negligible cash for the comparable prior year period.  The Company attributes these changes to general payments in the normal course of business vendors in the normal course of business.

39

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (CONTINUED)

Liquidity and Capital Resources (Continued)

Operating Activities (Continued)

Changes in accrued payroll and related costs provided $0.2 million for the thirteen week period ended April 3, 2021 as compared to using $1.3 million for the thirteen week period ended March 28, 2020.  There are four primary factors that generally impact accrued payroll and related costs: 1) there is a general correlation to operating expenses as payroll and related costs is the Company’s largest expense group, so as operating costs increase or decrease, absent all other factors, so will the accrued payroll and related costs; 2) the Company pays the majority of its payroll every two weeks and normally has thirteen weeks in a fiscal quarter, which means that the Company normally has a major payroll on the last business day of every other quarter; 3) the timing of various payroll related payments varies in the normal course of business; and 4) most of the Company’s senior management participate in annual incentive plans and while progress advances are sometimes made during the fiscal year, these accrued bonus balances, to the extent they are projected to be achieved, generally accumulate throughout the year.  A significant portion of these incentive plan accruals are typically paid at the beginning of one fiscal year, pertaining to the prior fiscal year.   The Company’s last major payroll for the thirteen week period ended April 3, 2021 was paid on March 26, 2021.  During fiscal 2020, the Company deferred $3.3 million of employer payroll taxes under the CARES Act. These deferred payroll taxes must be paid in two equal installments at the end of calendar years 2021 and 2022.

Investing Activities

Investing activities used negligible cash for the thirteen week periods ended April 3, 2021 and March 28, 2020.  Investing activities for both periods presented were primarily related to expenditures for property and equipment.

Financing Activities

Financing activities provided $9.3 million of cash for the thirteen week period ended April 3, 2021 as compared to using cash of $1.9 million in the comparable prior year period.  The Company conducted net borrowings under its line of credit of $10.1 million during the thirteen week period ended April 3, 2021 as compared to $2.0 million in the comparable prior year period.  The primary reasons for net borrowings during the thirteen week period ended April 3, 2021 were the increase of $9.1 million in accounts receivable and the repurchase of common stock for $0.9 million.  The Company generated cash of $0.2 million and $0.1 million from sales of shares from its equity plans for the current period and the comparable prior year period, respectively.  The Company did not pay contingent consideration during the periods presented.

Borrowings under the Revolving Credit Facility bear interest at one of two alternative rates, as selected by the Company at each incremental borrowing.  These alternatives are: (i) LIBOR (London Interbank Offered Rate), plus applicable margin, typically borrowed in fixed 30-day increments or (ii) the agent bank’s prime rate generally borrowed over shorter durations.  The Company also pays unused line fees based on the amount of the Revolving Credit Facility that is not drawn.  Unused line fees are recorded as interest expense.  The effective weighted average interest rate, including unused line fees, for the thirteen week period ended April 3, 2021 was 2.4%.

All borrowings under the Revolving Credit Facility are collateralized by all of the assets of the Company and its subsidiaries and a pledge of the stock of its subsidiaries.  The Revolving Credit Facility also contains various financial and non-financial covenants, such as a covenant that restricts the Company’s ability to borrow in order to pay dividends.  As of April 3, 2021, the Company was in compliance with all covenants contained in the Revolving Credit Facility (as amended).The Company believes that it will maintain compliance with its financial covenants for the foreseeable future.

Borrowings under the line of credit as of April 3, 2021 and January 2, 2021 were $22.0 million and $11.9 million, respectively.  At April 3, 2021 and January 2, 2021 there were letters of credit outstanding for $1.9 million.  At April 3, 2021, the Company had availability for additional borrowings under the Revolving Credit Facility of $21.1 million.

40

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (CONTINUED)

Liquidity and Capital Resources (Continued)

Financing Activities (Continued)

Impact to Line of Credit from COVID-19

The Company is negatively impacted by COVID-19.  While COVID-19 is expected to continue to negatively impact revenue, gross profit, and operating income for an undetermined period of time, the Company nevertheless does not expect a material negative impact from recent results.  If the Company should experience a sudden increase to revenue and a corresponding increase to accounts receivable, the Company will likely experience negative cash flow.  In this scenario, the Company would expect to see an increase in operating income and borrowing capacity.  As a response to COVID-19, the Company, as a whole, is focused on maximizing the utilization of its billable personnel and reducing its SGA expense in the short-term while not harming the Company in the long-term. The Company plans to refine its strategy for responding to COVID-19 as the situation develops. The Company believes that its current line of credit is adequate to provide the necessary liquidity while COVID-19 impacts its operations.  The Company believes that it will be in compliance with the financial covenants in the line of credit for the foreseeable future.

Current Liquidity and Revolving Credit Facility

Liquidity is a measure of our ability to meet potential cash requirements, maintain our assets, fund our operations, and meet the other general cash needs of our business. Our liquidity is impacted by general economic, financial, competitive, and other factors beyond our control. Our liquidity requirements consist primarily of funds necessary to pay our expenses, principally labor-costs, and other related expenditures. We generally satisfy our liquidity needs through cash provided by operations and, when necessary, our revolving line of credit from Citizens Bank. The Company believes it has a great deal of flexibility to reduce its costs if it becomes necessary. The Company believes that it can satisfy its liquidity needs for at least the next twelve months.

The Company’s liquidity and capital resources as of April 3, 2021, included accounts receivable and total current asset balances of $45.3 million and $54.1 million, respectively. Current liabilities were $28.0 million as of April 3, 2021 and total current assets exceeded total current liabilities by $26.1 million.

The Company experiences volatility in its daily cash flow and, at times, relies on the revolving line of credit to provide daily liquidity for the Company’s financial operations.  As of April 3, 2021, the Company was in compliance with all financial covenants contained in the Revolving Credit Facility.  The Company believes that it will maintain compliance with its financial covenants for the foreseeable future.

41

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (CONTINUED)

Liquidity and Capital Resources (Continued)

Commitments and Contingencies

The Company anticipates that its primary uses of capital in future periods will be for working capital purposes.  Funding for any long-term and short-term capital requirements as well as future acquisitions will be derived from one or more of the Revolving Credit Facility (or a replacement thereof), funds generated through operations or future financing transactions.  The Company is subject to legal proceedings and claims that arise from time to time in the ordinary course of its business, which may or may not be covered by insurance.  Were an unfavorable final outcome to occur, there exists the possibility of a material adverse impact on our financial position, liquidity, and the results of operations.

The Company’s business strategy is to achieve growth both internally through operations and externally through strategic acquisitions.  The Company from time to time engages in discussions with potential acquisition candidates. The Company has acquired numerous companies throughout its history and those acquisitions have generally included significant future contingent consideration.  As the size of the Company and its financial resources increase however, acquisition opportunities requiring significant commitments of capital may arise.  In order to pursue such opportunities, the Company may be required to incur debt or issue potentially dilutive securities in the future.  No assurance can be given as to the Company’s future acquisition and expansion opportunities or how such opportunities will be financed.

The Company has reserved $1.7 million for the settlement of a class action suit in California that alleges the Company did not properly pay its travel nurses overtime wages. While the Company believes it did not violate any overtime wage laws, it nevertheless decided to settle this class action lawsuit in December 2020.  The Company expects to pay the $1.7 million settlement sometime during the third quarter of fiscal 2021.  The Company is exposed to other asserted claims as of April 3, 2021, but the Company does not believe any of these other claims have a probability of loss. As of April 3, 2021, the Company did not have an accrual for any such other claims.  Furthermore, even if any of these other claims do result in an unfavorable outcome or settlement, the Company believes that such matters will not, either individually or in the aggregate, have a material adverse effect on its business, consolidated financial position, results of operations, or cash flows.

The Company utilizes SAP software for its financial reporting and accounting system which was implemented in 1999 and has not undergone significant upgrades since its initial implementation.  The Company believes that it will become necessary to upgrade or replace its SAP financial reporting and accounting system.  The Company has not determined when this contemplated replacement may be necessary.  The Company estimates this upgrade or replacement of its financial reporting and accounting system will cost between $0.5 million and $1.0 million.  These estimates are subject to material change.

The Company’s current commitments consist primarily of lease obligations for office space.  The Company believes that its capital resources are sufficient to meet its present obligations and those to be incurred in the normal course of business for at least the next 12 months.

The Company leases office facilities and various equipment under non-cancelable leases expiring at various dates through November 2025.  Certain leases are subject to escalation clauses based upon changes in various factors.

42

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (CONTINUED)

Liquidity and Capital Resources (Continued)

Future Contingent Payments

Maturities of lease liabilities are as follows:

Fiscal Year	Operating Leases		Finance Leases
2021 (after April 3, 2021)	$1,574		$180
2022	1,532		108
2023	967		-
2024	233		-
2025	48		-
Total lease payments	4,354		288
Less: imputed interest	(193	)	(9	)
Total	$4,161		$279

As of April 3, 2021, the Company had two active acquisition agreements whereby additional contingent consideration may be earned by the former shareholders: 1) effective October 1, 2017, the Company acquired all of the stock of PSR Engineering Solutions d.o.o. Beograd (Voždovac) (“PSR”) and 2) effective September 30, 2018, the Company acquired certain assets of Thermal Kinetics Engineering, PLLC and Thermal Kinetics Systems, LLC (together, “TKE”). The Company estimates future contingent payments at April 3, 2021 as follows:

Fiscal Year Ending	Total
January 1, 2022 (after April 3, 2021)	$520
December 31, 2022	2,364
Estimated future contingent consideration payments	$2,884

Estimates of future contingent payments are subject to significant judgment and actual payments may materially differ from estimates.  Potential future contingent payments to be made to all active acquisitions after April 3, 2021 are capped at a cumulative maximum of $3.1 million.  The Company estimates future contingent consideration payments based on forecasted performance and recorded the fair value of those expected payments as of April 3, 2021.  During the thirteen week period ended April 3, 2021, the Company measured the intangibles acquired at fair value on a non-recurring basis.  Contingent consideration related to acquisitions is recorded at fair value (level 3) with changes in fair value recorded in other (expense) income, net.

43

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The Company’s exposure to market risk for changes in interest rates relates primarily to the Company’s investment portfolio and debt instruments, which primarily consist of the Revolving Credit Facility. The Company does not have any derivative financial instruments in its portfolio.  The Company places its investments in instruments that meet high credit quality standards.  The Company is adverse to principal loss and ensures the safety and preservation of its invested funds by limiting default risk, market risk and reinvestment risk.  As of April 3, 2021 the Company’s investments consisted of cash and money market funds.  The Company does not use interest rate derivative instruments to manage its exposure to interest rate changes.  Based on the Company’s variable-rate line of credit balances during the thirteen week period ended April 3, 2021, if the interest rate on the Company’s variable-rate line of credit (using an incremental borrowing rate) during the period had been 1.0% higher, the Company’s interest expense on an annualized basis would have increased by $0.2 million.  The Company does not expect any material loss with respect to its investment portfolio.

ITEM 4. CONTROLS AND PROCEDURES

The Company’s management, under the supervision and with the participation of the Company’s Principal Executive Officer and Principal Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this report.  Based upon that evaluation, the Principal Executive Officer and Principal Financial Officer concluded that those disclosure controls and procedures as of the end of the period covered by this report were effective to provide reasonable assurance that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and is accumulated and communicated to the Company’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.

A controls system, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the controls system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.

As management prepares and executes a virtual financial close process, for the first time, there could be related implications on the internal controls performed specifically in conjunction with the preparation, review, and filing of this report. There is a risk that moving to a virtual environment in response to COVID-19 could result in certain controls (e.g., financial closing and reporting controls) being overridden or performed less frequently, or that management could be designing and implementing new controls in response to new risks. In addition, in instances where relevant controls fail, and there are no compensating controls in place, there may be fewer opportunities to timely identify or remediate control deficiencies.  There were otherwise no changes in the Company’s internal control over financial reporting during the quarter ended April 3, 2021, that materially affected or are reasonably likely to materially affect the Company’s internal control over financial reporting.

44

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

See discussion of Contingencies in Note 16 to the Condensed Consolidated Financial Statements included in Item 1 of this report.

ITEM 1A. RISK FACTORS

For information regarding factors that could affect the Company’s business, see the risk factors discussed under Part I, Item 1A, Risk Factors, of the Company’s Annual Report on Form 10-K for the fiscal year ended January 2, 2021.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Period	Total Number of Shares Purchased	Weighted Average Price Paid per Share	Total Number of Shares Purchased as Part of Publicly Announced Program	Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program
January 3, 2021 - January 31, 2021	259,167	$2.52	259,167	$6,847,000
February 1, 2021 - February 28, 2021	68,405	$2.92	327,572	$6,647,000
March 1, 2021 - April 3, 2021	16,600	$3.48	344,172	$6,589,000
Total	344,172	$2.65	344,172	$6,589,000

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None.

45

ITEM 6. EXHIBITS

10.1	Amendment to RCM Technologies, Inc. 2014 Omnibus Equity Compensation Plan; incorporated by reference to Exhibit 99.1 to the Registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on January 15, 2021.
31.1*	Certification of Principal Executive Officer Required by Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.
31.2*	Certification of Principal Financial Officer Required by Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.
32.1**	Certification of Principal Executive Officer Required by Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended.  (This exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section.  Further, this exhibit shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.)
32.2**	Certification of Principal Financial Officer Required by Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended.  (This exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section.  Further, this exhibit shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.)
101.INS*	XBRL Instance Document
101.SCH*	XBRL Taxonomy Extension Schema Document
101.CAL*	XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB*	XBRL Taxonomy Extension Label Linkbase Document
101.PRE*	XBRL Taxonomy Extension Presentation Linkbase Documents
101.DEF*	XBRL Taxonomy Definition Linkbase Document

__________

*Filed herewith

**Furnished herewith

46

RCM TECHNOLOGIES, INC.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	RCM Technologies, Inc.
Date:  May 14, 2021	By: /s/ Bradley S. Vizi
		Bradley S. Vizi Executive Chairman and President (Principal Executive Officer and Duly Authorized Officer of the Registrant)

Date:  May 14, 2021	By: /s/ Kevin D. Miller
		Kevin D. Miller Chief Financial Officer (Principal Financial Officer and Duly Authorized Officer of the Registrant)

47

Exhibit 31.1

RCM TECHNOLOGIES, INC.

CERTIFICATIONS REQUIRED BY
RULE 13a-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

CERTIFICATION

I, Bradley S. Vizi, certify that:

1.I have reviewed this quarterly report on Form 10-Q of RCM Technologies, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)  designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this  report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)disclosed in this annual report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:  May 14, 2021 /s/ Bradley S. Vizi Bradley S. Vizi Executive Chairman and President

48

Exhibit 31.2

RCM TECHNOLOGIES, INC.

CERTIFICATIONS REQUIRED BY
RULE 13a-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

CERTIFICATION

I, Kevin D. Miller, certify that:

1.I have reviewed this quarterly report on Form 10-Q of RCM Technologies, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)  designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)disclosed in this annual report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:  May 14, 2021 /s/ Kevin D. Miller Kevin D. Miller Chief Financial Officer

49

Exhibit 32.1

RCM TECHNOLOGIES, INC.

CERTIFICATIONS REQUIRED BY
RULE 13a-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

I, Bradley S. Vizi, Executive Chairman and President of RCM Technologies, Inc., a Nevada corporation (the “Company”), hereby certify that, to my knowledge:

(1)  The Company’s periodic report on Form 10-Q for the quarter ended April 3, 2021 (the “Form 10-Q”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended; and

(2)   The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

***

/s/ Bradley S. Vizi

Bradley S. Vizi

Executive Chairman and President

Date:  May 14, 2021

50

Exhibit 32.2

RCM TECHNOLOGIES, INC.

CERTIFICATIONS REQUIRED BY
RULE 13a-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

I, Kevin D. Miller, Chief Financial Officer of RCM Technologies, Inc., a Nevada corporation (the “Company”), hereby certify that, to my knowledge:

(1)  The Company’s periodic report on Form 10-Q for the quarter ended April 3, 2021 (the “Form 10-Q”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended; and

(2)  The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

***

/s/ Kevin D. Miller

Kevin D. Miller

Chief Financial Officer

Date:  May 14, 2021

51

EX-31.1

Exhibit 31.1

RCM TECHNOLOGIES, INC.

CERTIFICATIONS REQUIRED BY
RULE 13a-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

CERTIFICATION

I, Bradley S. Vizi, certify that:

1.I have reviewed this quarterly report on Form 10-Q of RCM Technologies, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)  designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this  report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)disclosed in this annual report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:  May 14, 2021 /s/ Bradley S. Vizi Bradley S. Vizi Executive Chairman and President

EX-31.2

Exhibit 31.2

RCM TECHNOLOGIES, INC.

CERTIFICATIONS REQUIRED BY
RULE 13a-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

CERTIFICATION

I, Kevin D. Miller, certify that:

1.I have reviewed this quarterly report on Form 10-Q of RCM Technologies, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)  designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)disclosed in this annual report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:  May 14, 2021 /s/ Kevin D. Miller Kevin D. Miller Chief Financial Officer

EX-32.1

Exhibit 32.1

RCM TECHNOLOGIES, INC.

CERTIFICATIONS REQUIRED BY
RULE 13a-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

I, Bradley S. Vizi, Executive Chairman and President of RCM Technologies, Inc., a Nevada corporation (the “Company”), hereby certify that, to my knowledge:

(1)  The Company’s periodic report on Form 10-Q for the quarter ended April 3, 2021 (the “Form 10-Q”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended; and

(2)   The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

***

/s/ Bradley S. Vizi

Bradley S. Vizi

Executive Chairman and President

Date:  May 14, 2021

EX-32.2

Exhibit 32.2

RCM TECHNOLOGIES, INC.

CERTIFICATIONS REQUIRED BY
RULE 13a-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

I, Kevin D. Miller, Chief Financial Officer of RCM Technologies, Inc., a Nevada corporation (the “Company”), hereby certify that, to my knowledge:

(1)  The Company’s periodic report on Form 10-Q for the quarter ended April 3, 2021 (the “Form 10-Q”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended; and

(2)  The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

***

/s/ Kevin D. Miller

Kevin D. Miller

Chief Financial Officer

Date:  May 14, 2021

XML

Document And Entity Information - shares	3 Months Ended
	Apr. 03, 2021	May 13, 2021
Document Information [Line Items]
Entity Registrant Name	RCM TECHNOLOGIES, INC.
Entity Central Index Key	0000700841
Trading Symbol	rcmt
Current Fiscal Year End Date	--01-01
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Interactive Data Current	Yes
Entity Common Stock, Shares Outstanding (in shares)		11,089,084
Entity Shell Company	false
Document Type	10-Q
Document Period End Date	Apr. 03, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q1
Amendment Flag	false
Title of 12(b) Security	Common Stock, par value $0.05 per share

XML

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Apr. 03, 2021	Jan. 02, 2021
Current assets:
Cash and cash equivalents	$ 678	$ 734
Accounts receivable, net	45,282	36,007
Transit accounts receivable	3,947	2,494
Prepaid expenses and other current assets	4,201	4,699
Total current assets	54,108	43,934
Property and equipment, net	1,859	2,078
Other assets:
Deposits	169	169
Deferred tax asset, net, domestic	3,002	3,300
Goodwill	16,354	16,354
Operating right of use asset	2,263	2,409
Intangible assets, net	15	95
Total other assets	21,803	22,327
Total assets	77,770	68,339
Current liabilities:
Accounts payable and accrued expenses	7,326	7,895
Transit accounts payable	4,551	4,900
Accrued payroll and related costs	12,894	12,877
Finance lease payable	183	247
Income taxes payable	351	436
Operating right of use liability	1,937	1,886
Liability for contingent consideration from acquisitions	520	500
Total current liabilities	27,762	28,741
Finance lease payable	96	106
Liability for contingent consideration from acquisitions	2,364	2,358
Operating right of use liability, net of current position	2,224	2,641
Borrowings under line of credit	22,029	11,890
Total liabilities	54,844	46,101
Commitments and contingencies (note 16)
Stockholders’ equity:
Preferred stock, $1.00 par value; 5,000,000 shares authorized; no shares issued or outstanding
Common stock, $0.05 par value; 40,000,000 shares authorized; 16,510,793 shares issued and 11,485,310 shares outstanding at April 3, 2021 and 16,224,191 shares issued and 11,542,880 shares outstanding at January 2, 2021	826	811
Stock subscription receivable	(323)	(420)
Additional paid-in capital	110,179	109,588
Accumulated other comprehensive loss	(2,661)	(2,550)
Accumulated deficit	(66,967)	(67,974)
Treasury stock (5,025,483 shares at April 3, 2021 and (4,681,311 shares at January 2, 2021) at cost	(18,128)	(17,217)
Stockholders’ equity	22,926	22,238
Total liabilities and stockholders’ equity	77,770	68,339
Foreign Tax Authority [Member]
Current liabilities:
Deferred tax liability	$ 369	$ 365

XML

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Apr. 03, 2021	Jan. 02, 2021
Preferred stock par value (in dollars per share)	$ 1	$ 1
Preferred stock, authorized (in shares)	5,000,000	5,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.05	$ 0.05
Common stock, authorized (in shares)	40,000,000	40,000,000
Common stock, issued (in shares)	16,510,793	16,224,191
Common stock, outstanding (in shares)	11,485,310	11,542,880
Treasury stock, shares (in shares)	5,025,483	4,681,311

XML

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Apr. 03, 2021	Mar. 28, 2020
Revenue	$ 44,549	$ 45,033
Cost of services	33,699	34,190
Gross profit	10,850	10,843
Operating costs and expenses
Selling, general and administrative	9,069	10,237
Depreciation and amortization of property and equipment	266	255
Amortization of acquired intangible assets	80	80
Write-off of receivables and professional fees incurred related to arbitration		8,047
Tax credit professional fees	60
Operating costs and expenses	9,475	18,619
Operating income (loss)	1,375	(7,776)
Other expense (income)
Interest expense and other, net	121	340
Change in fair value of contingent consideration	26	36
Loss (gain) on foreign currency transactions	(135)	33
Other expense, net	12	409
Income (loss) before income taxes	1,363	(8,185)
Income tax expense (benefit)	356	(2,240)
Net income (loss)	$ 1,007	$ (5,945)
Basic net earnings (loss) per share (in dollars per share)	$ 0.09	$ (0.45)
Diluted net earnings (loss) per share (in dollars per share)	$ 0.08	$ (0.45)

XML

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Apr. 03, 2021	Mar. 28, 2020
Net income (loss)	$ 1,007	$ (5,945)
Other comprehensive loss	(111)	(131)
Comprehensive income (loss)	$ 896	$ (6,076)

XML

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Treasury Stock [Member]	Stock Subscriptions Receivable [Member]	Total
Balance (in shares) at Dec. 28, 2019	15,826,891				2,823,172
Balance at Dec. 28, 2019	$ 791	$ 108,452	$ (2,748)	$ (59,105)	$ (14,987)		$ 32,403
Issuance of stock under employee stock purchase plan (in shares)	57,251
Issuance of stock under employee stock purchase plan	$ 3	137					140
Equity compensation expense from awards issued		69					69
Issuance of stock upon vesting of restricted share awards (in shares)	60,000
Issuance of stock upon vesting of restricted share awards	$ 3	(3)
Purchase of treasury stock (in shares)							0
Foreign currency translation adjustment			(131)				$ (131)
Net income (loss)				(5,945)			(5,945)
Issuance of equity awards (in shares)	60,000
Balance (in shares) at Mar. 28, 2020	15,944,142				2,823,172
Balance at Mar. 28, 2020	$ 797	108,655	(2,879)	(65,050)	$ (14,987)		26,536
Balance (in shares) at Jan. 02, 2021	16,224,191				4,681,311
Balance at Jan. 02, 2021	$ 811	109,588	(2,550)	(67,974)	$ (17,217)	$ (420)	22,238
Issuance of stock under employee stock purchase plan (in shares)	53,906
Issuance of stock under employee stock purchase plan	$ 3	58					61
Stock subscription receivable (in shares)	57,696
Stock subscription receivable	$ 3	(3)				97	97
Equity compensation expense from awards issued		545					545
Issuance of stock upon vesting of restricted share awards (in shares)	175,000
Issuance of stock upon vesting of restricted share awards	$ 9	(9)
Purchase of treasury stock (in shares)					344,172		344,172
Purchase of treasury stock					$ (911)		$ (911)
Foreign currency translation adjustment			(111)				(111)
Net income (loss)				1,007			1,007
Issuance of equity awards (in shares)	175,000
Balance (in shares) at Apr. 03, 2021	16,510,793				5,025,483
Balance at Apr. 03, 2021	$ 826	$ 110,179	$ (2,661)	$ (66,967)	$ (18,128)	$ (323)	$ 22,926

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Apr. 03, 2021	Mar. 28, 2020
Cash flows from operating activities:
Net income (loss)	$ 1,007	$ (5,945)
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	346	335
Change in fair value of contingent consideration	26	36
Equity compensation expense	362	69
Provision for losses on accounts receivable	(150)	7,792
Deferred income tax expense (benefit)	302	(2,217)
Changes in assets and liabilities:
Accounts receivable	(9,085)	974
Prepaid expenses and other current assets	582	166
Net of transit accounts receivable and payable	(1,802)	973
Accounts payable and accrued expenses	(588)	(6)
Accrued payroll and related costs	187	(1,289)
Right of use assets	146	304
Right of use liabilities	(366)	(284)
Income taxes payable	(157)	21
Total adjustments	(10,197)	6,874
Net cash (used in) provided by operating activities	(9,190)	929
Cash flows from investing activities:
Property and equipment acquired	(47)	(35)
Net cash used in investing activities	(47)	(35)
Cash flows from financing activities:
Borrowings under line of credit	26,186	22,279
Repayments under line of credit	(16,046)	(24,273)
Issuance of stock for employee stock purchase plan	60	140
Stock subscription	97
Changes in finance lease obligations	(71)	(80)
Common stock repurchase	(911)
Net cash provided by (used in) financing activities	9,315	(1,934)
Effect of exchange rate changes on cash and cash equivalents	(134)	(165)
Decrease in cash and cash equivalents	(56)	(1,205)
Cash and cash equivalents at beginning of period	734	1,847
Cash and cash equivalents at end of period	678	642
Supplemental cash flow information:
Interest	254	420
Income taxes	236	43
Non-cash financing activities:
Equity awards issued	$ 380	$ 172

XML

Note 1 - Basis of Presentation

3 Months Ended

Apr. 03, 2021

Notes to Financial Statements

Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]

1. Basis of Presentation

The accompanying condensed consolidated interim financial statements of RCM Technologies, Inc. and subsidiaries (“RCM” or the “Company”) are unaudited. The year-end consolidated balance sheet was derived from audited statements but does

not

include all disclosures required by accounting principles generally accepted in the United States. These statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission pertaining to reports on Form

10

-Q and should be read in conjunction with the Company's consolidated financial statements and the notes thereto for the year ended

January 2, 2021

included in the Company's Annual Report Form

10

-K for such period. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations.

The condensed consolidated financial statements for the unaudited interim periods presented include all adjustments (consisting only of normal, recurring adjustments) necessary for a fair presentation of financial position, results of operations and cash flows for such interim periods.

Results for the

thirteen

week period ended

April 3, 2021

are

not

necessarily indicative of results that

may

be expected for the full year.

Fiscal Year

The Company follows a

52/53

week fiscal reporting calendar ending on the Saturday closest to

December 31.

The current fiscal year ended

January 1, 2022 (

fiscal

2021

) is a

52

-week reporting year. The prior fiscal year ending

January 2, 2021 (

fiscal

2020

) was a

53

-week reporting year. The fiscal quarters for the current year (fiscal

2021

) and the prior year (fiscal

2020

) align as follows:

Fiscal 2021 Quarters	Weeks	Fiscal 2020 Quarters	Weeks
April 3, 2021	Thirteen	March 28, 2020	Thirteen
July 3, 2021	Thirteen	June 27, 2020	Thirteen
October 2, 2021	Thirteen	September 26, 2020	Thirteen
January 1, 2022	Thirteen	January 2, 2021	Fourteen

Current Liquidity and Revolving Credit Facility

Liquidity is a measure of our ability to meet potential cash requirements, maintain our assets, fund our operations, and meet the other general cash needs of our business. Our liquidity is impacted by general economic, financial, competitive, and other factors beyond our control. Our liquidity requirements consist primarily of funds necessary to pay our expenses, principally labor-costs, and other related expenditures. We generally satisfy our liquidity needs through cash provided by operations and, when necessary, our revolving line of credit from Citizens Bank. The Company believes it has a great deal of flexibility to reduce its costs if it becomes necessary. The Company believes that it can satisfy its liquidity needs for at least the next

twelve

months.

The Company's liquidity and capital resources as of

April 3, 2021,

included accounts receivable and total current asset balances of

$45.3

million and

$54.1

million, respectively. Current liabilities were

$28.0

million as of

April 3, 2021

and total current assets exceeded total current liabilities by

$26.1

million.

The Company experiences volatility in its daily cash flow and, at times, relies on the revolving line of credit to provide daily liquidity for the Company's financial operations. As of

April 3, 2021,

the Company was in compliance with all financial covenants contained in the revolving line of credit. The Company believes that it will maintain compliance with its financial covenants for the foreseeable future.

XML

Note 2 - Use of Estimates and Uncertainties

3 Months Ended

Apr. 03, 2021

Notes to Financial Statements

Basis of Presentation and Significant Accounting Policies [Text Block]

2. Use of Estimates and Uncertainties

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenue and expenses and disclosure of contingent assets and liabilities. Actual results could differ from those estimates.

The Company uses estimates to calculate an allowance for doubtful accounts on its accounts receivables, adequacy of reserves, goodwill impairment, if any, equity compensation, the tax rate applied and the valuation of certain assets and liability accounts. These estimates can be significant to the operating results and financial position of the Company. The estimates are based upon various factors including current and historical trends, as well as other pertinent industry and regulatory authority information, including the potential future effects of COVID-

19.

Management regularly evaluates this information to determine if it is necessary to update the basis for its estimates and to adjust for known changes.

The Company has risk participation arrangements with respect to workers compensation and health care insurance. The amounts included in the Company's costs related to this risk participation are estimated and can vary based on changes in assumptions, the Company's claims experience or the providers included in the associated insurance programs.

The Company can be affected by a variety of factors including uncertainty relating to the performance of the general economy, competition, demand for the Company's services, adverse litigation and claims and the hiring, training and retention of key employees.

Fair Value of Financial Instruments

The Company's carrying value of financial instruments, consisting primarily of accounts receivable, transit accounts receivable, accounts payable and accrued expenses, and transit accounts payable and borrowings under line of credit approximates fair value due to their liquidity or their short-term nature and the line of credit's variable interest rate. The Company does

not

have derivative products in place to manage risks related to foreign currency fluctuations for its foreign operations or for interest rate changes.

The Company re-measures the fair value of the contingent consideration at each reporting period and any change in the fair value from either the passage of time or events occurring after the acquisition date, is recorded in earnings in the accompanying consolidated statement of operations.

XML

Note 3 - Revenue Recognition

3 Months Ended

Apr. 03, 2021

Notes to Financial Statements

Revenue from Contract with Customer [Text Block]

3. Revenue Recognition

The Company records revenue under Accounting Standards Codification ("ASC") Topic

606,

 

Revenue from Contracts with Customers

. Revenue is recognized when we satisfy a performance obligation by transferring services promised in a contract to a customer, in an amount that reflects the consideration that we expect to receive in exchange for those services. Performance obligations in our contracts represent distinct or separate service streams that we provide to our customers.

We evaluate our revenue contracts with customers based on the

five

-step model under ASC

606:

(

1

) Identify the contract with the customer; (

2

) Identify the performance obligations in the contract; (

3

) Determine the transaction price; (

4

) Allocate the transaction price to separate performance obligations; and (

5

) Recognize revenue when (or as) each performance obligation is satisfied.

The Company derives its revenue from several sources. The Company's Engineering Services and Information Technology segments perform consulting and project solution services. The Healthcare segment specializes in long-term and short-term staffing and placement services to hospitals, schools and long-term care facilities amongst others. All of the Company's segments perform staff augmentation services and derive revenue from permanent placement fees. The majority of the Company's revenue is invoiced on a time and materials basis.

The following table presents our revenue disaggregated by revenue source for the

thirteen

week periods ended

April 3, 2021

and

March 28, 2020:

	Thirteen Week Periods Ended
	April 3, 2021		March 28, 2020
Engineering:
Time and Material	$	10,478	$	12,827
Fixed Fee		3,921		1,314
Permanent Placement Services		67		22
Total Engineering	$	14,466	$	14,163
Specialty Health Care:
Time and Material	$	20,933	$	22,053
Permanent Placement Services		204		144
Total Specialty Health Care	$	21,137	$	22,197
Information Technology:
Time and Material	$	8,796	$	8,557
Permanent Placement Services		150		116
Total Information Technology	$	8,946	$	8,673
	$	44,549	$	45,033

Time and Material

The Company's IT and Healthcare segments predominantly recognize revenue through time and material work while its Engineering segment recognizes revenue through both time and material and fixed fee work. The Company's time and material contracts are typically based on the number of hours worked at contractually agreed upon rates, therefore revenue associated with these time and materials contracts are recognized based on hours worked at contracted rates. 

Fixed Fee

From time to time and predominantly in our Engineering segment, the Company will enter into contracts requiring the completion of specific deliverables.  The Company has master services agreements with many of its customers that broadly define terms and conditions. Actual services performed under fixed fee arrangements are typically delivered under purchase orders that more specifically define terms and conditions related to that fixed fee project. While these master services agreements can often span several years, the Company's fixed fee purchase orders are typically performed over

six

to

nine

month periods.  In instances where project services are provided on a fixed-price basis, revenue is recorded in accordance with the terms of each contract.  In certain instances, revenue is invoiced at the time certain milestones are reached, as defined in the contract.  Revenue under these arrangements are recognized as the costs on these contracts are incurred.  On an infrequent basis, amounts paid in excess of revenue earned and recognized are recorded as deferred revenue, included in accounts payable and accrued expenses on the accompanying condensed balance sheets.  Additionally, some contracts contain “Performance Fees” (bonuses) for completing a contract under budget.  Performance Fees, if any, are recorded when earned.  Some contracts also limit revenue and billings to specified maximum amounts.  Provisions for contract losses, if any, are made in the period such losses are determined.  For contracts where there is a specific deliverable and the work is

not

complete and the revenue is

not

recognized, the costs incurred are deferred as a prepaid asset.  The associated costs are expensed when the related revenue is recognized.

Permanent Placement Services

The Company earns permanent placement fees from providing permanent placement services. These fees are typically based on a percentage of the compensation paid to the person placed with the Company's client.

There was

$0.1

million deferred revenue as of

April 3, 2021.

Deferred revenue was

$0.4

million as of

January 2, 2021

and was included in accounts payable and accrued expenses in the accompanying condensed consolidated balance sheet at that date.  Revenue is recognized when the service has been performed. Deferred revenue

may

be recognized over a period exceeding

one

year from the time it was recorded on the balance sheet. For the

thirteen

week periods ended

April 3, 2021

and

March 28, 2020,

the Company recognized

$0.3

million and

$0.4

million that was included in deferred revenue at the beginning of each respective reporting period.

XML

Note 4 - Accounts Receivable, Transit Accounts Receivable and Transit Accounts Payable

3 Months Ended

Apr. 03, 2021

Notes to Financial Statements

Loans, Notes, Trade and Other Receivables Disclosure [Text Block]

4. Accounts Receivable, Transit Accounts Receivable and Transit Accounts Payable

The Company's accounts receivable are comprised as follows:

	April 3, 2021			January 2, 2021
Billed	$	31,529		$	25,926
Accrued and unbilled		11,636			8,219
Work-in-progress		3,535			3,612
Allowance for sales discounts and doubtful accounts		(1,418	)		(1,750	)
Accounts receivable, net	$	45,282		$	36,007

Unbilled receivables primarily represent revenue earned whereby those services are ready to be billed as of the balance sheet ending date. Work-in-progress primarily represents revenue earned under contracts which the Company contractually invoices at future dates.

From time to time, the Company's Engineering segment enters into agreements to provide, among other things, construction management and engineering services.  Pursuant to these agreements, the Company a)

may

engage subcontractors to provide construction or other services; b) typically earns a fixed percentage of the total project value; and c) assumes

no

ownership or risks of inventory.  Under the terms of the agreements, the Company is typically

not

required to pay the subcontractor until after the corresponding payment from the Company's end-client is received. Upon invoicing the end-client on behalf of the subcontractor or staffing agency the Company records this amount simultaneously as both a “transit account receivable” and “transit account payable” as the amount when paid to the Company is due to and generally paid to the subcontractor within a few days. The Company typically does

not

pay a given transit account payable until the related transit account receivable is collected. The Company is typically obligated to pay the subcontractor or staffing agency whether or

not

the client pays the Company. The Company's transit accounts payable generally exceeds the Company's transit accounts receivable but absolute amounts and spreads fluctuate significantly from quarter to quarter in the normal course of business. The transit accounts receivable was

$3.9

million and related transit accounts payable was

$4.5

million, for a net payable of

$0.6

million, as of

April 3, 2021.

The transit accounts receivable was

$2.5

million and related transit accounts payable was

$4.9

million, for a net payable of

$2.4

million, as of

January 2, 2021.

XML

Note 5 - Property and Equipment

3 Months Ended

Apr. 03, 2021

Notes to Financial Statements

Property, Plant and Equipment Disclosure [Text Block]

5. Property and Equipment

Property and equipment are stated at cost and are depreciated on the straight-line method at rates calculated to provide for retirement of assets at the end of their estimated useful lives. The annual rates are

20%

for computer hardware and software as well as furniture and office equipment. Leasehold improvements are amortized over the shorter of the estimated life of the asset or the lease term.

Property and equipment are comprised of the following:

	April 3, 2021		January 2, 2021
Computers and systems	$	4,410	$	4,686
Equipment and furniture		137		264
Leasehold improvements		234		235
		4,781		5,185
Less: accumulated depreciation and amortization		2,922		3,107
Property and equipment, net	$	1,859	$	2,078

The Company periodically writes off fully depreciated and amortized assets.  The Company wrote off fully depreciated and amortized assets of

$451

and

$960

during the

thirteen

week periods ended

April 3, 2021

and

March 28, 2020,

respectively. Depreciation and amortization expense of property and equipment for the

thirteen

week periods ended

April 3, 2021

and

March 28, 2020

was

$266

and

$255,

respectively.

XML

Note 6 - Acquisitions

3 Months Ended

Apr. 03, 2021

Notes to Financial Statements

Business Combination Disclosure [Text Block]

6. Acquisitions

The Company has acquired numerous companies throughout its history and those acquisitions have generally included significant future contingent consideration. The Company gives

no

assurance that it will make acquisitions in the future or that if it does make acquisitions, such acquisitions will be successful.

Future Contingent Payments

As of

April 3, 2021,

the Company had

two

active acquisition agreements whereby additional contingent consideration

may

be earned by the former shareholders:

1

) effective

October 1, 2017,

the Company acquired all of the stock of PSR Engineering Solutions d.o.o. Beograd (Voždovac) (“PSR”) and

2

) effective

September 30, 2018,

the Company acquired certain assets of Thermal Kinetics Engineering, PLLC and Thermal Kinetics Systems, LLC (together, “TKE”). The Company estimates future contingent payments at

April 3, 2021

as follows:

Fiscal Year Ending	Total
January 1, 2022 (after April 3, 2021)	$	520
December 31, 2022		2,364
Estimated future contingent consideration payments	$	2,884

Estimates of future contingent payments are subject to significant judgment and actual payments

may

materially differ from estimates. Potential future contingent payments to be made to all active acquisitions after

April 3, 2021

are capped at a cumulative maximum of

$3.1

million. The Company estimates future contingent consideration payments based on forecasted performance and recorded the fair value of those expected payments as of

April 3, 2021. 

During the

thirteen

week period ended

April 3, 2021,

the Company measured contingent consideration at fair value on a non-recurring basis. Contingent consideration related to acquisitions is recorded at fair value (level

3

) due to the lack of observable market inputs. Changes in fair value are recorded in other (expense) income, net.

For acquisitions that involve contingent consideration, the Company records a liability equal to the fair value of the estimated contingent consideration obligation as of the acquisition date. The Company determines the acquisition date fair value of the contingent consideration based on the likelihood of paying the additional consideration. The fair value is estimated using projected future operating results and the corresponding future earn-out payments that can be earned upon the achievement of specified operating objectives and financial results by acquired companies using Level

3

inputs and the amounts are then discounted to present value. These liabilities are measured quarterly at fair value, and any change in the fair value of the contingent consideration liability is recognized in the consolidated statements of operations. During the measurement period, which

may

be up to

one

year from the acquisition date, the Company records adjustments to the assets acquired and liabilities assumed with the corresponding adjustment to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recognized in the consolidated statements of operations.

The Company did

not

pay contingent consideration during the

thirteen

week periods ended

April 3, 2021

and

March 28, 2020.

XML

Note 7 - Goodwill

3 Months Ended

Apr. 03, 2021

Notes to Financial Statements

Goodwill Disclosure [Text Block]

7. Goodwill

Goodwill represents the premium paid over the fair value of the net tangible and intangible assets acquired in business combinations.  The Company tests goodwill for impairment on an annual basis as of the last day of the Company's fiscal year or more frequently if events occur or circumstances change indicating that the fair value of goodwill

may

be below the carrying amount.  During the

thirteen

week period ended

April 3, 2021,

the Company reviewed the carrying value of goodwill due to the events and circumstances surrounding the COVID-

19

pandemic. While COVID-

19

has negatively impacted the Company, and the Company expects this negative impact to continue at least through the

first

half of fiscal

2021

and likely beyond, the Company did

not

conclude in such review that this negative impact is permanent. The Company has determined that

no

other indicators of impairment of goodwill existed during the

thirteen

week period ended

April 3, 2021.

As such,

no

impairment loss on the Company's goodwill during the

thirteen

week period ended

April 3, 2021

was recorded as a result of such review.

The carrying amount of goodwill as of

April 3, 2021

and

January 2, 2021

is as follows:

Engineering		Specialty Health Care		Information Technology		Total
$	11,918	$	2,398	$	2,038	$	16,354

XML

Note 8 - Intangible Assets

3 Months Ended

Apr. 03, 2021

Notes to Financial Statements

Intangible Assets Disclosure [Text Block]

8. Intangible Assets

The Company evaluates long-lived assets and intangible assets with definite lives for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset

may

not

be recoverable. When the Company determines that it is probable that undiscounted future cash flows will

not

be sufficient to recover an asset's carrying amount, the asset is written down to its fair value. Assets to be disposed of by sale, if any, are reported at the lower of the carrying amount or fair value less cost to sell. The Company's intangible assets consist of customer relationships and non-compete agreements. During the

thirteen

week period ended

April 3, 2021,

the Company reviewed the carrying value of its intangible assets due to the events and circumstances surrounding the COVID-

19

pandemic. While COVID-

19

has negatively impacted the Company, and the Company expects this negative impact to continue at least through the balance of fiscal

2021,

the Company does

not

believe at this time that this negative impact is permanent. As such,

no

impairment loss on the Company's intangible assets during the

thirteen

week period ended

April 3, 2021

was recorded as a result of such review.

All of the Company's intangible assets are associated with the Engineering segment.  Intangible assets other than goodwill are amortized over their useful lives.  Intangible assets are carried at cost, less accumulated amortization.

Details of intangible assets by class at

April 3, 2021

and

January 2, 2021:

	April 3, 2021		January 2, 2021
Restricted covenants	$	8	$	12
Customer relationships		7		83
Total intangible assets	$	15	$	95

Amortization expense of acquired intangible assets for both of the

thirteen

week periods ended

April 3, 2021

and

March 28, 2020

was

$80.

XML

Note 9 - Line of Credit

3 Months Ended

Apr. 03, 2021

Notes to Financial Statements

Debt Disclosure [Text Block]

9. Line of Credit

The Company and its subsidiaries amended and restated its Revolving Credit Facility with Citizens Bank of Pennsylvania on

October 18, 2019. 

As amended and restated, the Revolving Credit Facility provides for a

$45.0

million revolving credit facility, has

no

sub-limit for letters of credit, and expires on

August 8, 2023.

On

September 29, 2020,

the Company entered into an amendment to its Revolving Credit Facility. The amendment (i) modifies certain aspects of the financial covenants under the Loan Agreement, including the manner in which the measurement periods for certain components of the financial covenants are determined, (ii) modifies the required compliance levels for certain ratios under the Loan Agreement, and (iii) permitted the repayment of

$2.2

million of indebtedness to a

third

party incurred in connection with the previously disclosed

June 2020

repurchase of stock.

Borrowings under the Revolving Credit Facility bear interest at

one

of

two

alternative rates, as selected by the Company at each incremental borrowing.  These alternatives are: (i) LIBOR (London Interbank Offered Rate), plus applicable margin, typically borrowed in fixed

30

-day increments or (ii) the agent bank's prime rate generally borrowed over shorter durations.  The Company also pays unused line fees based on the amount of the Revolving Credit Facility that is

not

drawn.  Unused line fees are recorded as interest expense.  The effective weighted average interest rate, including unused line fees, for the

thirteen

week periods ended

April 3, 2021

and

March 28, 2020

were

2.4%

and

3.7%,

respectively.

All borrowings under the Revolving Credit Facility are collateralized by all of the assets of the Company and its subsidiaries and a pledge of the stock of its subsidiaries. The Revolving Credit Facility also contains various financial and non-financial covenants, such as a covenant that restricts the Company's ability to borrow in order to pay dividends. As of

April 3, 2021,

the Company was in compliance with all covenants contained in the Revolving Credit Facility (as amended).The Company believes that it will maintain compliance with its financial covenants for the foreseeable future.

Borrowings under the line of credit as of

April 3, 2021

and

January 2, 2021

were

$22.0

million and

$11.9

million, respectively. At both

April 3, 2021

and

January 2, 2021

there were letters of credit outstanding for

$1.9

million. At

April 3, 2021

and

January 2, 2021,

the Company had availability for additional borrowings under the Revolving Credit Facility of

$21.1

million and

$31.2

million, respectively.

Impact to Line of Credit from COVID-

19

The Company is negatively impacted by COVID-

19

as more fully described in Footnote

19.

The Company believes that its current line of credit is adequate to provide the necessary liquidity while COVID-

19

impacts its operations. While the Company does expect to be in compliance with its financial covenants in the line of credit for the foreseeable future, the Company can give

no

assurance that the line of credit will be available to the Company.

XML

Note 10 - Per Share Data

3 Months Ended

Apr. 03, 2021

Notes to Financial Statements

Earnings Per Share [Text Block]

10. Per Share Data

The Company uses the treasury stock method to calculate the weighted-average shares used for diluted earnings per share. The number of common shares used to calculate basic and diluted earnings (loss) per share for the

thirteen

week periods ended

April 3, 2021

and

March 28, 2020

was determined as follows:

	Thirteen Week Periods Ended
	April 3, 2021		March 28, 2020
Basic weighted average shares outstanding		11,539,389		13,111,550
Dilutive effect of outstanding restricted share awards		389,857		-
Weighted average dilutive shares outstanding		11,929,246		13,111,550

For all periods presented, there were

no

anti-dilutive shares

not

included in the calculation of common stock equivalents as there were

no

stock options outstanding.

Unissued shares of common stock were reserved for the following purposes:

	April 3, 2021		January 2, 2021
Time-based restricted stock units outstanding		506,554		459,805
Unvested subscription restricted share awards		192,304		250,000
Performance-based restricted stock units outstanding		90,000		-
Future grants of options or shares		209,180		520,929
Shares reserved for employee stock purchase plan		95,988		149,894
Total		1,094,026		1,380,628

XML

Note 11 - Share Based Compensation

3 Months Ended

Apr. 03, 2021

Notes to Financial Statements

Share-based Payment Arrangement [Text Block]

11. Share-Based Compensation

At

April 3, 2021,

the Company had

two

share-based employee compensation plans. The Company measures the fair value of share-based awards, if and when granted, based on the Black-Scholes method and using the closing market price of the Company's common stock on the date of grant. Awards typically vest over periods ranging from

one

to

three

years and expire within

10

years of issuance. The Company

may

also issue immediately vested equity awards. Share-based compensation expense related to time-based awards is amortized in accordance with applicable vesting periods using the straight-line method. The Company expenses performance-based awards only when the performance metrics are likely to be achieved and the associated awards are therefore likely to vest. Performance-based share awards that are likely to vest are also expensed on a straight-line basis over the vesting period but

may

vest on a retroactive basis or be reversed, depending on when it is determined that they are likely to vest, or in the case of a reversal when they are later determined to be unlikely to vest.

Share-based compensation expense for the

thirteen

week periods ended

April 3, 2021,

and

March 28, 2020

was

$362

and

$69,

respectively.  As of

April 3, 2021,

there were

90,000

performance-based restricted stock units outstanding.

As of

April 3, 2021,

the Company had

$1.1

million of total unrecognized compensation cost related to all time-based non-vested share-based awards outstanding. The Company expects to recognize this expense over approximately

two

years.  These amounts do

not

include a) performance-based restricted stock units, b) the cost of any additional share-based awards granted in future periods or c) the impact of any potential changes in the Company's forfeiture rate. 

Incentive Share-Based Plans

2014

Omnibus Equity Compensation Plan (the

2014

Plan)

The

2014

Plan, approved by the Company's shareholders in

December 2014,

initially provided for the issuance of up to

625,000

shares of the Company's common stock to officers, non-employee directors, employees of the Company and its subsidiaries, or consultants and advisors utilized by the Company.  In fiscal

2016

and fiscal

2020,

the Company amended and restated the

2014

Plan with shareholder approval to increase the aggregate number of shares of stock reserved for issuance under the Plan by an additional

500,000

and

850,000

shares, respectively, so that the total number of shares of stock reserved for issuance under the Plan is

1,975,000

shares.  The expiration date of the Plan is

December 17, 2030,

unless the

2014

Plan is terminated earlier by the Board or is extended by the Board with the approval of the stockholders.  The Compensation Committee of the Board of Directors determines the vesting period at the time of grant. 

As of

April 3, 2021,

under the

2014

Plan,

698,858

time-based shares were outstanding, there were

90,000

performance-based restricted share units outstanding and

209,180

shares were available for awards thereunder.

The market value of equity grants issued for the

thirteen

week periods ended

April 3, 2021

and

March 28, 2020

was

$835

and

$423

respectively. 

Employee Stock Purchase Plan

The Company implemented the

2001

Employee Stock Purchase Plan (the “Purchase Plan”) with shareholder approval, effective

January 1, 2001.

Under the Purchase Plan, employees meeting certain specific employment qualifications are eligible to participate and can purchase shares of common stock semi-annually through payroll deductions at the lower of

85%

of the fair market value of the stock at the commencement or end of the offering period. The purchase plan permits eligible employees to purchase shares of common stock through payroll deductions for up to

10%

of qualified compensation, subject to maximum purchases in any

one

fiscal year of

3,000

shares.

In fiscal

2015,

the Company amended the Purchase Plan with shareholder approval to increase the aggregate number of shares of stock reserved for issuance or transfer under the Plan by an additional

300,000

shares so that the total number of shares of stock reserved for issuance or transfer under the Plan shall be

1,100,000

shares and to extend the expiration date of the Plan to

December 31, 2025.

In fiscal

2018,

the Company amended the Purchase Plan with shareholder approval to increase the aggregate number of shares of stock reserved for issuance or transfer under the Plan by an additional

300,000

shares so that the total number of shares of stock reserved for issuance or transfer under the Plan shall be

1,400,000

shares.

The Company has

two

offering periods in the Purchase Plan coinciding with the Company's

first

two

fiscal quarters and the last

two

fiscal quarters. Actual shares are issued on the

first

business day of the subsequent offering period for the prior offering period payroll deductions. The number of shares issued on

January 4, 2021 (

the

first

business day following the previous offering period) was

53,906.

As of

April 3, 2021,

there were

95,988

shares available for issuance under the Purchase Plan.

Time-Based Restricted Stock Awards / Stock Subscription Receivable

From time-to-time the Company issues time-based restricted stock units. These time-based restricted stock units typically include dividend accrual equivalents, which means that any dividends paid by the Company during the vesting period become due and payable after the vesting period assuming the grantee's restricted stock unit fully vests. Dividends for these grants are accrued on the dividend payment dates and included in accounts payable and accrued expenses on the accompanying condensed consolidated balance sheet. As of

April 3, 2021,

there were

no

accrued dividends. Dividends for time-based restricted stock units that ultimately do

not

vest are forfeited.

The following summarizes the activity in the time-based restricted stock units under the

2014

Plan during the

thirteen

week period ended

April 3, 2021:

	Number of Time-Based Restricted Stock Units			Weighted Average Grant Date Fair Value per Share
Outstanding non-vested at January 2, 2021		709,805		$	1.92
Granted		96,749		$	2.80
Vested		(107,696	)	$	2.21
Forfeited or expired		-			-
Outstanding non-vested at April 3, 2021		698,858		$	2.00

Based on the closing price of the Company's common stock of

$3.75

per share on

April 1, 2021 (

the last trading day prior to

April 3, 2021),

the intrinsic value of the time-based non-vested restricted stock units at

April 3, 2021

was approximately

$2.6

million. As of

April 3, 2021,

there was approximately

$1.1

million of total unrecognized compensation cost related to time-based restricted stock units, which is expected to be recognized over the average weighted remaining vesting period of the restricted stock units.

In

December 2020,

the Company granted members of senior management

one

-time restricted stock awards of an aggregate of

250,000

shares in exchange for a stock subscription receivable. The shares will be acquired by senior management through repayment of the stock subscription receivable over

twelve

months beginning in

January 2021

and ending in

December 2021.

During the

thirteen

week period ended

April 3, 2021,

the Company awarded

125,000

immediately vested share awards at an average price of

$2.17.

During fiscal

2020,

the Company awarded

100,092

immediately vested share awards at an average price of

$1.33.

Performance Based Restricted Stock Units

From time-to-time the Company issues performance-based restricted stock awards to its executives.  Performance-based restricted stock awards are typically vested based on certain multi-year performance metrics as determined by the Board of Directors Compensation Committee. These performance-based restricted stock awards typically include dividend accrual equivalents, which means that any dividends paid by the Company during the vesting period become due and payable after the vesting period on any stock awards that actually vest, if any.  Dividends for these grants are accrued on the dividend payment dates and included in accounts payable and accrued expenses on the accompanying condensed consolidated balance sheet.  As of

April 3, 2021,

there were

no

accrued dividends for performance-based restricted stock units. Dividends for performance-based restricted stock units that ultimately do

not

vest are forfeited.  

To date, the Company has issued performance-based restricted stock units only under the

2014

Plan.  The following summarizes the activity in the performance-based restricted stock units during the

thirteen

week period ended

April 3, 2021:

	Number of Performance-Based Restricted Stock Units		Weighted Average Grant Date Fair Value per Share
Outstanding non-vested at January 2, 2021		-		-
Granted		90,000	$	3.26
Vested		-		-
Forfeited or expired		-		-
Outstanding non-vested at April 3, 2021		90,000	$	3.26

As of

April 3, 2021,

there were

90,000

performance-based restricted stock units outstanding. The Company assesses at each reporting date whether achievement of any performance condition is probable and recognizes the expense when achievement of the performance condition becomes probable.  The Company will then recognize the appropriate expense cumulatively in the year performance becomes probable and recognize the remaining compensation cost over the remaining requisite service period. If at a later measurement date the Company determines that performance-based restricted stock awards deemed as likely to vest are deemed as unlikely to vest, the expense recognized will be reversed.

XML

Note 12 - Treasury Stock Transactions

3 Months Ended

Apr. 03, 2021

Notes to Financial Statements

Treasury Stock [Text Block]

12. Treasury Stock Transactions

On

January 13, 2021,

the Company's Board of Directors authorized a program to repurchase shares of the Company's common stock constituting, in the aggregate, up to an amount

not

to exceed

$7.5

million, consistent with the maximum limitation set forth by the Company's revolving line of credit. The program is designed to provide the Company with enhanced flexibility over the long term to optimize its capital structure. Shares of the common stock

may

be repurchased in the open market or through negotiated transactions. The program

may

be terminated or suspended at any time at the discretion of the Company.

During the

thirteen

week period ended

April 3, 2021,

the Company purchased

344,172

shares at an average price of

$2.65

per share. During the

thirteen

week period ended

March 28, 2020,

the Company did

not

purchase any shares. As of

April 3, 2021,

the Company has

$6.6

million available for future treasury stock purchases.

XML

Note 13 - New Accounting Standards and Updates from the Securities Exchange Commission ("SEC")

3 Months Ended

Apr. 03, 2021

Notes to Financial Statements

Accounting Standards Update and Change in Accounting Principle [Text Block]

13. New Accounting Standards and Updates from the Securities Exchange Commission ( “ SEC ” )

In

June 2016,

the FASB issued ASU

2016

-

13,

Financial Instruments - Credit Losses (Topic

326

).

The new standard amends guidance on reporting credit losses for assets held at amortized cost basis and available-for-sale debt securities. In

February 2020,

the FASB issued ASU

2020

-

02,

Financial Instruments-Credit Losses (Topic

326

) and Leases (Topic

842

) - Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin

No.

119

and Update to SEC Section on Effective Date Related to Accounting Standards Update

No.

2016

-

02,

Leases (Topic

842

),

 which amends the effective date of the original pronouncement for smaller reporting companies.  ASU

2016

-

13

and its amendments will be effective for the Company for interim and annual periods in fiscal years beginning after

December 15, 2022.  

The Company believes the adoption will modify the way the Company analyzes financial instruments, but it does

not

anticipate a material impact on results of operations. The Company is in the process of determining the effects the adoption will have on its condensed consolidated financial statements.

In

March 2020,

the FASB issued ASU

No.

2020

-

04,

Reference Rate Reform (Topic

848

): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.

This standard only applies to contracts and other transactions that reference London Interbank Offered Rate (LIBOR) or another reference rate expected to be discontinued due to reference rate reform. This guidance provides temporary optional expedients and exceptions to accounting guidance on contract modifications and hedge accounting to ease entities' financial reporting burdens as the market transitions from the LIBOR and other interbank offered rates to alternative reference rates. The Company

may

elect to apply the amendments prospectively through

December 31, 2022.

The Company is currently evaluating the impact this guidance will have on its condensed consolidated financial statements and related disclosures.

XML

Note 14 - Segment Information

3 Months Ended

Apr. 03, 2021

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

14. Segment Information

The Company follows

ASC280,

“Segment Reporting,” which establishes standards for companies to report information about operating segments, geographic areas and major customers. The accounting policies of each reportable segment are the same as those described in the summary of significant accounting policies (see Note

1

to the Company's Condensed Consolidated Financial Statements included in its Annual Report on Form

10

-K for the year ended

January 2, 2021).

Segment operating income (loss) includes selling, general and administrative expenses directly attributable to that segment as well as charges for allocating corporate costs to each of the operating segments. The following tables reflect the results of the reportable segments consistent with the Company's management system:

Thirteen Week Period Ended April 3, 2021	Engineering			Specialty Health Care		Information Technology		Corporate			Total
Revenue	$	14,466		$	21,137	$	8,946	$	-		$	44,549
Cost of services		11,260			16,099		6,340		-			33,699
Gross profit		3,206			5,038		2,606		-			10,850
Selling, general and administrative		3,074			4,064		1,931		-			9,069
Depreciation and amortization of property and equipment		156			82		28		-			266
Amortization of acquired intangible assets		80			-		-		-			80
Tax credit professional fees		-			-		-		60			60
Operating income (loss)	$	(104	)	$	892	$	647	$	(60	)	$	1,375
Total assets as of April 3, 2021	$	35,898		$	26,111	$	8,385	$	7,376		$	77,770
Capital expenditures	$	9		$	28	$	6	$	4		$	47

Thirteen Week Period Ended March 28, 2020	Engineering			Specialty Health Care			Information Technology		Corporate		Total
Revenue	$	14,163		$	22,197		$	8,673	$	-	$	45,033
Cost of services		10,205			17,812			6,173		-		34,190
Gross profit		3,958			4,385			2,500		-		10,843
Selling, general and administrative		3,424			4,400			2,413		-		10,237
Depreciation and amortization		238			77			20		-		335
Write-off of receivables related to arbitration		8,047			-			-		-		8,047
Operating income (loss)	$	(7,751	)	$	(92	)	$	67	$	-	$	(7,776	)
Total assets as of March 28, 2020	$	43,690		$	25,499		$	8,717	$	6,045	$	83,951
Capital expenditures	$	9		$	10		$	15	$	1	$	35

The Company derives a majority of its revenue from offices in the United States. Revenue reported for each operating segment are all from external customers. The Company is domiciled in the United States and its segments operate in the United States, Canada, Puerto Rico and Serbia. Revenue by geographic area for the

thirteen

week periods ended

April 3, 2021

and

March 28, 2020

are as follows:

	Thirteen Week Periods Ended
	April 3, 2021		March 28, 2020
Revenue
U. S.	$	39,007	$	39,176
Canada		3,385		4,002
Puerto Rico		1,515		1,202
Serbia		642		653
	$	44,549	$	45,033

Total assets by geographic area as of the reported periods are as follows:

	April 3, 2021		January 2, 2021
Total assets
U. S.	$	64,680	$	56,308
Canada		7,720		7,067
Puerto Rico		1,669		1,483
Serbia		3,701		3,481
	$	77,770	$	68,339

XML

Note 15 - Income Taxes

3 Months Ended

Apr. 03, 2021

Notes to Financial Statements

Income Tax Disclosure [Text Block]

15. Income Taxes

The Company recognized

$0.4

million of income tax expense for the

thirteen

week period ended

April 3, 2021,

as compared to

$2.2

million of income tax benefit for the comparable prior year period.  The consolidated effective income tax rate for the current period was

26.1%

as compared to

27.4%

for the comparable prior year period. The projected fiscal

2021

income tax rates as of

April 3, 2021,

were approximately

28.0%,

26.5%

and

15.1%

in the United States, Canada and Serbia, respectively. The relative income or loss generated in each jurisdiction can materially impact the overall effective income tax rate of the Company, particularly the ratio of Canadian and Serbian pretax income versus U.S. pretax income.  The comparable prior year period estimated income tax rates were

27.0%,

28.1%

and

15.5%

in the United States, Canada and Serbia, respectively. 

Differences between the effective tax rate and the applicable U.S. federal statutory rate

may

arise, primarily from the effect of state and local income taxes, share-based compensation, and potential tax credits available to the Company. The actual

2021

effective tax rate

may

vary from the estimate depending on the actual operating income earned in various jurisdictions, the potential availability of tax credits, and the exercise of stock options and vesting of share-based awards. The Company's estimate for the

2021

effective tax rate has

not

been adjusted for any potential impact related to COVID-

19.

XML

Note 16 - Contingencies

3 Months Ended

Apr. 03, 2021

Notes to Financial Statements

Contingencies Disclosure [Text Block]

16. Contingencies

From time to time, the Company is a defendant or plaintiff in various legal actions that arise in the ordinary business course.  These matters

may

relate to professional liability, tax, compensation, contract, competitor disputes, and employee-related matters and include individual and class action lawsuits, as well as inquiries and investigations by governmental agencies regarding the Company's employment and compensation practices. Additionally, some of the Company's clients

may

also become subject to claims, governmental inquiries and investigations, and legal actions relating to the Company's professional services. Depending upon the particular facts and circumstances, the Company

may

also be subject to indemnification obligations under its contracts with such clients relating to these matters.

As such, the Company is required to assess the likelihood of any adverse outcomes to these matters as well as potential ranges of losses and possible recoveries.  The Company

may

not

be covered by insurance as it pertains to some or all of these matters.  A determination of the amount of the provision required for these commitments and contingencies, if any, which would be charged to earnings, is made after careful analysis of each matter.  The Company records a liability when management believes an adverse outcome from a loss contingency is both probable and the amount, or a range, can be reasonably estimated. Significant judgment is required to determine both probability of loss and the estimated amount. The Company reviews its loss contingencies at least quarterly and adjusts its accruals and/or disclosures to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, or other new information, as deemed necessary. Once established, a provision

may

change in the future due to new developments or changes in circumstances and could increase or decrease the Company's earnings in the period that the changes are made. 

The Company is exposed to various asserted claims as of

April 3, 2021,

where the Company believes it has a probability of loss. As of

April 3, 2021,

the Company has accrued

$1.8

million for asserted claims of

$2.0

million.  Additionally, the Company is exposed to other asserted claims whereby an amount of loss has

not

been declared, and the Company can't determine the potential loss. Any of these various claims could result in an unfavorable outcome or settlement that exceeds the accrued amounts. However, the Company believes that such matters will

not,

either individually or in the aggregate, have a material adverse effect on its business, consolidated financial position, results of operations, or cash flows. Included in the

April 3. 2021

accrual of

$1.8

million, the Company has reserved

$1.7

million for the settlement of a class-action suit in California that alleges the Company did

not

properly pay its travel nurses overtime wages. While the Company believes it did

not

violate any overtime wage laws, it nevertheless decided to settle this class action lawsuit in

December 2020. 

The Company expects to pay the

$1.7

million settlement sometime during the

third

quarter of fiscal

2021.

XML

Note 17 - Leases

3 Months Ended

Apr. 03, 2021

Notes to Financial Statements

Lessee, Operating Leases [Text Block]

17. Leases

Leases are recorded in accordance with FASB ASC

842,

Leases which requires lessees to recognize a right-of-use (“ROU”) asset and an operating right of use liability for all leases with terms greater than

12

months and requires disclosures by lessees and lessors about the amount, timing and uncertainty of cash flows arising from leases.

The Company determines if an arrangement is a lease at inception. For leases where the Company is the lessee, right of use assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. Right of use assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As most of the Company's leases do

not

provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments

.

The right of use asset also consists of any lease incentives received. The lease terms used to calculate the right of use asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as depreciation expense and interest expense using the accelerated interest method of recognition. The Company has lease agreements which require payments for lease and non-lease components. The Company has elected to account for these as a single lease component with the exception of its real estate leases.

The components of lease expense were as follows:

	Thirteen Week Periods Ended
	April 3, 2021		March 28, 2020
Operating lease cost	$	537	$	656
Amortization of right of use assets	$	91	$	78
Interest on lease liabilities	$	2	$	2
Total finance lease cost	$	93	$	80

Supplemental Cash Flow information related to leases was as follows:

	Thirteen Week Period Ended
	April 3, 2021		March 28, 2020
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases	$	552	$	663
Operating cash flows from finance leases	$	1	$	2
Financing cash flows from finance leases	$	74	$	80
Right of use assets obtained in exchange for lease obligations
Operating leases	$	145	$	250
Finance leases		-		-

Supplemental Balance Sheet information as of

April 3, 2021

and

January 2, 2021

related to leases was as follows:

	April 3, 2021			January 2, 2021
Operating leases
Operating lease right of use assets	$	2,263		$	2,409
Operating right of use liability - current	$	(1,937	)	$	(1,886	)
Operating right of use liability - non-current		(2,224	)		(2,641	)
Total operating lease liabilities	$	(4,161	)	$	(4,527	)
Property and equipment - (right of use assets)	$	1,140		$	1,140
Accumulated depreciation		(837	)		(746	)
Property and equipment, net	$	303		$	394
Finance lease liability - current	$	(183	)	$	(247	)
Finance lease liability - non-current		(96	)		(106	)
Total finance lease liabilities	$	(279	)	$	(353	)
Weighted average remaining lease term
Operating leases (years)		1.36			2.03
Finance leases (years)		1.43			1.45
Weighted average discount rate
Operating leases		3.08	%		4.06	%
Finance leases		2.88	%		2.63	%

Maturities of lease liabilities are as follows:

Fiscal Year	Operating Leases			Finance Leases
2021 (after April 3, 2021)	$	1,574		$	180
2022		1,532			108
2023		967			-
2024		233			-
2025		48			-
Total lease payments		4,354			288
Less: imputed interest		(193	)		(9	)
Total	$	4,161		$	279

XML

Note 18 - Stockholder Rights Plan

3 Months Ended

Apr. 03, 2021

Notes to Financial Statements

Stockholders' Equity Note Disclosure [Text Block]

18. Stockholder Rights Plan

On

May 22, 2020,

the Board of Directors of the Company approved a stockholder rights plan (the “Rights Plan”) and declared a dividend distribution to stockholders of record as of the close of business on

June 2, 2020

of

one

preferred stock purchase right (a“Right”) for each outstanding share of Common Stock of the Company.Each Right entitles the holder to purchase from the Company a unit consisting of

one one

-hundredth of a share (a “Unit”) of a newly-authorized series of junior participating preferred stock of the Company, upon the occurrence of certain events, as more fully described below, at a purchase price of

$5.60

per Unit

.

In connection with the adoption of the stockholder rights plan, the Company designated

250,000

shares of the Company's authorized shares of Preferred Stock, par value

$1.00,

as Series A-

3

Junior Participating Preferred Shares,

none

of which are issued and outstanding. As provided in the Certificate of Designation filed by the Company with the Department of State of the State of Nevada, each Series A-

3

Preferred Share shall entitle the holder

100

votes on all matters submitted to a vote of the stockholders of the Company, subject to adjustment for future dividends and combinations of common stock. The holders of Series A-

3

Preferred Shares and the holders of shares of Common Stock shall vote together as

one

class on all matters submitted to a vote of stockholders of the Company. The Series A-

3

Preferred Shares shall, after issuance, be entitled to receive quarterly dividends in an amount equal to the greater of

$50.00

per share or an amount per share, subject to adjustment, equal to

100

times the aggregate per share amount of all non-cash dividends or other distributions other than a dividend payable in shares of common stock or a subdivision of the outstanding shares of common stock declared on the common stock since the immediately preceding quarterly dividend payment date of the Series A-

3

Preferred Shares, or, with respect to the

first

such quarterly dividend payment date, since the

first

issuance of any share or fraction of a share of the Series A-

3

Preferred Shares. The Series A-

3

Preferred Shares shall rank junior to all other series of the Company's Preferred Stock as to the payment of dividends and the distribution of assets, unless the terms of any such series shall provide otherwise. The Series A-

3

Preferred Shares shall

not

be redeemable. In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company, the holders of Series A-

3

Preferred Shares shall be entitled to receive the greater of

$100.00

per share, plus accrued dividends, or an amount per share, subject to adjustment, equal to

100

times the aggregate amount to be distributed per share to holders of Common Stock. In the event the Company shall enter into any consolidation, merger, combination or other transaction in which the shares of Common Stock are exchanged for or changed into other stock or securities, cash and/or any other property, then in any such event the Series A-

3

Preferred Shares shall at the same time be similarly exchanged or changed in an amount per share, subject to adjustment, equal to

100

times the aggregate amount of stock, securities, cash and/or any other property (payable in kind), as the case

may

be, into which or for which each share of Common Stock is changed or exchanged. These preferences are protected by customary anti-dilution provisions.

Initially, the Rights are

not

exercisable and are attached to each existing outstanding share of the Company's Common Stock. The Rightswill separate and become exercisable if a person or group acquires

10%

or more of the Company's Common Stock in a transaction, including the open market purchase of shares,

not

approved by our Board. If a person or group acquires

10%,

each Right will entitle its holder (other than such person or members of such group) to purchase, at the Right's exercise price (subject to adjustment as provided in the Rights Plan), a number of shares of the Company's Common Stock having a then-current market value of twice the exercise price.The Rights Plan will cause substantial dilution to a person or group that attempts to acquire control of the Company on terms or in a manner

not

approved by our Board.

The initial issuance of the Rights as a dividend had

no

financial accounting or reporting impact. The fair value of the Rights was nominal because the Rights were

not

exercisable when issued and

no

value is attributable to them. Additionally, the Rights do

not

meet the definition of a liability under generally accepted accounting principles in the United States and are therefore

not

accounted for as a long-term obligation. Accordingly, unless the Rights become exercisable as discussed above, the Rights Plan has

no

impact on the Company's Condensed Consolidated Financial Statements

.

The Company's Board of Directors

may

redeem the Rights for

$0.001

per Right at any time before an event that causes the Rights to become exercisable. The Rights will expire on

May 22, 2021,

unless the Rights have previously been redeemed by the Board of Directors.

The Rights Plan is

not

intended to interfere with any merger, tender or exchange offer or other business combination approved byour Board. Nor does the Rights Plan prevent ourBoard from considering any offer that it considers to be in the best interest of its stockholders.

XML

Note 19 - COVID-19

3 Months Ended

Apr. 03, 2021

Notes to Financial Statements

Effect of COVID-19 Pandemic [Text Block]

19. COVID- 19

In

March 2020,

the World Health Organization declared the outbreak of a novel coronavirus (COVID-

19

) as a pandemic, which continues to present various health, business and other challenges throughout the United States. As a result, we have temporarily closed most of our office locations, with most of our workforce working from home, and have seen a reduction in customer demand, all resulting in a negative impact on Company revenue, gross profit, and operating income. The duration and ultimate magnitude of the disruption remains uncertain. Therefore, while we experienced a negative impact during fiscal

2020

and our

first

quarter of fiscal

2021,

we expect this matter to continue to negatively impact our business, results of operations, and financial position throughout fiscal

2021

and possibly beyond, and the related financial impact cannot be reasonably estimated at this time.

XML

Note 3 - Revenue Recognition (Tables)

3 Months Ended

Apr. 03, 2021

Notes Tables

Disaggregation of Revenue [Table Text Block]

	Thirteen Week Periods Ended
	April 3, 2021		March 28, 2020
Engineering:
Time and Material	$	10,478	$	12,827
Fixed Fee		3,921		1,314
Permanent Placement Services		67		22
Total Engineering	$	14,466	$	14,163
Specialty Health Care:
Time and Material	$	20,933	$	22,053
Permanent Placement Services		204		144
Total Specialty Health Care	$	21,137	$	22,197
Information Technology:
Time and Material	$	8,796	$	8,557
Permanent Placement Services		150		116
Total Information Technology	$	8,946	$	8,673
	$	44,549	$	45,033

XML

Note 4 - Accounts Receivable, Transit Accounts Receivable and Transit Accounts Payable (Tables)

3 Months Ended

Apr. 03, 2021

Notes Tables

Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]

	April 3, 2021			January 2, 2021
Billed	$	31,529		$	25,926
Accrued and unbilled		11,636			8,219
Work-in-progress		3,535			3,612
Allowance for sales discounts and doubtful accounts		(1,418	)		(1,750	)
Accounts receivable, net	$	45,282		$	36,007

XML

Note 5 - Property and Equipment (Tables)

3 Months Ended

Apr. 03, 2021

Notes Tables

Property, Plant and Equipment [Table Text Block]

	April 3, 2021		January 2, 2021
Computers and systems	$	4,410	$	4,686
Equipment and furniture		137		264
Leasehold improvements		234		235
		4,781		5,185
Less: accumulated depreciation and amortization		2,922		3,107
Property and equipment, net	$	1,859	$	2,078

XML

Note 6 - Acquisitions (Tables)

3 Months Ended

Apr. 03, 2021

Notes Tables

Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]

Fiscal Year Ending	Total
January 1, 2022 (after April 3, 2021)	$	520
December 31, 2022		2,364
Estimated future contingent consideration payments	$	2,884

XML

Note 7 - Goodwill (Tables)

3 Months Ended

Apr. 03, 2021

Notes Tables

Schedule of Goodwill [Table Text Block]

Engineering		Specialty Health Care		Information Technology		Total
$	11,918	$	2,398	$	2,038	$	16,354

XML

Note 8 - Intangible Assets (Tables)

3 Months Ended

Apr. 03, 2021

Notes Tables

Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]

	April 3, 2021		January 2, 2021
Restricted covenants	$	8	$	12
Customer relationships		7		83
Total intangible assets	$	15	$	95

XML

Note 10 - Per Share Data (Tables)

3 Months Ended

Apr. 03, 2021

Notes Tables

Schedule of Weighted Average Number of Shares [Table Text Block]

	Thirteen Week Periods Ended
	April 3, 2021		March 28, 2020
Basic weighted average shares outstanding		11,539,389		13,111,550
Dilutive effect of outstanding restricted share awards		389,857		-
Weighted average dilutive shares outstanding		11,929,246		13,111,550

Unissued Shares of Common Stock [Table Text Block]

	April 3, 2021		January 2, 2021
Time-based restricted stock units outstanding		506,554		459,805
Unvested subscription restricted share awards		192,304		250,000
Performance-based restricted stock units outstanding		90,000		-
Future grants of options or shares		209,180		520,929
Shares reserved for employee stock purchase plan		95,988		149,894
Total		1,094,026		1,380,628

XML

Note 11 - Share Based Compensation (Tables)

3 Months Ended

Apr. 03, 2021

Notes Tables

Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]

	Number of Time-Based Restricted Stock Units			Weighted Average Grant Date Fair Value per Share
Outstanding non-vested at January 2, 2021		709,805		$	1.92
Granted		96,749		$	2.80
Vested		(107,696	)	$	2.21
Forfeited or expired		-			-
Outstanding non-vested at April 3, 2021		698,858		$	2.00

	Number of Performance-Based Restricted Stock Units		Weighted Average Grant Date Fair Value per Share
Outstanding non-vested at January 2, 2021		-		-
Granted		90,000	$	3.26
Vested		-		-
Forfeited or expired		-		-
Outstanding non-vested at April 3, 2021		90,000	$	3.26

XML

Note 14 - Segment Information (Tables)

3 Months Ended

Apr. 03, 2021

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Thirteen Week Period Ended April 3, 2021	Engineering			Specialty Health Care		Information Technology		Corporate			Total
Revenue	$	14,466		$	21,137	$	8,946	$	-		$	44,549
Cost of services		11,260			16,099		6,340		-			33,699
Gross profit		3,206			5,038		2,606		-			10,850
Selling, general and administrative		3,074			4,064		1,931		-			9,069
Depreciation and amortization of property and equipment		156			82		28		-			266
Amortization of acquired intangible assets		80			-		-		-			80
Tax credit professional fees		-			-		-		60			60
Operating income (loss)	$	(104	)	$	892	$	647	$	(60	)	$	1,375
Total assets as of April 3, 2021	$	35,898		$	26,111	$	8,385	$	7,376		$	77,770
Capital expenditures	$	9		$	28	$	6	$	4		$	47

Thirteen Week Period Ended March 28, 2020	Engineering			Specialty Health Care			Information Technology		Corporate		Total
Revenue	$	14,163		$	22,197		$	8,673	$	-	$	45,033
Cost of services		10,205			17,812			6,173		-		34,190
Gross profit		3,958			4,385			2,500		-		10,843
Selling, general and administrative		3,424			4,400			2,413		-		10,237
Depreciation and amortization		238			77			20		-		335
Write-off of receivables related to arbitration		8,047			-			-		-		8,047
Operating income (loss)	$	(7,751	)	$	(92	)	$	67	$	-	$	(7,776	)
Total assets as of March 28, 2020	$	43,690		$	25,499		$	8,717	$	6,045	$	83,951
Capital expenditures	$	9		$	10		$	15	$	1	$	35

Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]

	Thirteen Week Periods Ended
	April 3, 2021		March 28, 2020
Revenue
U. S.	$	39,007	$	39,176
Canada		3,385		4,002
Puerto Rico		1,515		1,202
Serbia		642		653
	$	44,549	$	45,033

Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]

	April 3, 2021		January 2, 2021
Total assets
U. S.	$	64,680	$	56,308
Canada		7,720		7,067
Puerto Rico		1,669		1,483
Serbia		3,701		3,481
	$	77,770	$	68,339

XML

Note 17 - Leases (Tables)

3 Months Ended

Apr. 03, 2021

Notes Tables

Lease, Cost [Table Text Block]

	Thirteen Week Periods Ended
	April 3, 2021		March 28, 2020
Operating lease cost	$	537	$	656
Amortization of right of use assets	$	91	$	78
Interest on lease liabilities	$	2	$	2
Total finance lease cost	$	93	$	80

Lease, Cash Flow Information [Table Text Block]

	Thirteen Week Period Ended
	April 3, 2021		March 28, 2020
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases	$	552	$	663
Operating cash flows from finance leases	$	1	$	2
Financing cash flows from finance leases	$	74	$	80
Right of use assets obtained in exchange for lease obligations
Operating leases	$	145	$	250
Finance leases		-		-

Lease, Balance Sheet Information [Table Text Block]

	April 3, 2021			January 2, 2021
Operating leases
Operating lease right of use assets	$	2,263		$	2,409
Operating right of use liability - current	$	(1,937	)	$	(1,886	)
Operating right of use liability - non-current		(2,224	)		(2,641	)
Total operating lease liabilities	$	(4,161	)	$	(4,527	)
Property and equipment - (right of use assets)	$	1,140		$	1,140
Accumulated depreciation		(837	)		(746	)
Property and equipment, net	$	303		$	394
Finance lease liability - current	$	(183	)	$	(247	)
Finance lease liability - non-current		(96	)		(106	)
Total finance lease liabilities	$	(279	)	$	(353	)
Weighted average remaining lease term
Operating leases (years)		1.36			2.03
Finance leases (years)		1.43			1.45
Weighted average discount rate
Operating leases		3.08	%		4.06	%
Finance leases		2.88	%		2.63	%

Lease, Liability, Maturity [Table Text Block]

Fiscal Year	Operating Leases			Finance Leases
2021 (after April 3, 2021)	$	1,574		$	180
2022		1,532			108
2023		967			-
2024		233			-
2025		48			-
Total lease payments		4,354			288
Less: imputed interest		(193	)		(9	)
Total	$	4,161		$	279

XML

Note 1 - Basis of Presentation (Details Textual) - USD ($) $ in Thousands	Apr. 03, 2021	Jan. 02, 2021
Accounts Receivable, after Allowance for Credit Loss, Current, Total	$ 45,282	$ 36,007
Assets, Current, Total	54,108	43,934
Liabilities, Current, Total	27,762	$ 28,741
Excess of Current Assets over Current Liabilities	$ 26,100

XML

Note 3 - Revenue Recognition (Details Textual) - USD ($) $ in Millions	3 Months Ended
	Apr. 03, 2021	Mar. 28, 2020	Jan. 02, 2021
Contract with Customer, Liability, Revenue Recognized	$ 0.3	$ 0.4
Accounts Payable and Accrued Liabilities [Member]
Contract with Customer, Liability, Total	$ 0.1		$ 0.4

XML

Note 3 - Revenue Recognition - Revenues Disaggregated by Revenue Source (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 03, 2021	Mar. 28, 2020
Revenue	$ 44,549	$ 45,033
Engineering Services [Member]
Revenue	14,466	14,163
Health Care [Member]
Revenue	21,137	22,197
Technology Service [Member]
Revenue	8,946	8,673
Time-and-materials Contract [Member] | Engineering Services [Member]
Revenue	10,478	12,827
Time-and-materials Contract [Member] | Health Care [Member]
Revenue	20,933	22,053
Time-and-materials Contract [Member] | Technology Service [Member]
Revenue	8,796	8,557
Fixed-price Contract [Member] | Engineering Services [Member]
Revenue	3,921	1,314
Permanent Placement Services [Member] | Engineering Services [Member]
Revenue	67	22
Permanent Placement Services [Member] | Health Care [Member]
Revenue	204	144
Permanent Placement Services [Member] | Technology Service [Member]
Revenue	$ 150	$ 116

XML

Note 4 - Accounts Receivable, Transit Accounts Receivable and Transit Accounts Payable (Details Textual) - USD ($) $ in Millions	Apr. 03, 2021	Jan. 02, 2021
Transit Accounts Receivable [Member]
Accounts Receivable, before Allowance for Credit Loss, Current	$ 3.9	$ 2.5
Transit Accounts Payable [Member]
Accounts Payable, Current, Total	4.5	4.9
Accounts Payable, Net	$ 0.6	$ 2.4

XML

Note 4 - Accounts Receivable, Transit Accounts Receivable and Transit Accounts Payable - Accounts Receivable (Details) - USD ($) $ in Thousands	Apr. 03, 2021	Jan. 02, 2021
Allowance for sales discounts and doubtful accounts	$ (1,418)	$ (1,750)
Accounts receivable, net	45,282	36,007
Billed Revenues [Member]
Accounts receivable, current	31,529	25,926
Unbilled Revenues [Member]
Accounts receivable, current	11,636	8,219
Work In Progress [Member]
Accounts receivable, current	$ 3,535	$ 3,612

XML

Note 5 - Property and Equipment (Details Textual) - USD ($) $ in Thousands	3 Months Ended
	Apr. 03, 2021	Mar. 28, 2020	Jun. 27, 2020
Annual Depreciation Rate			20.00%
Write Off of Fully Depreciated Property and Equipment	$ 451	$ 960
Depreciation, Nonproduction	$ 266	$ 255

XML

Note 5 - Property and Equipment - Summary of Property and Equipment (Details) - USD ($) $ in Thousands	Apr. 03, 2021	Jan. 02, 2021
Property and equipment	$ 4,781	$ 5,185
Less: accumulated depreciation and amortization	2,922	3,107
Property and equipment, net	1,859	2,078
Computers and Systems [Member]
Property and equipment	4,410	4,686
Equipment and Furniture [Member]
Property and equipment	137	264
Leasehold Improvements [Member]
Property and equipment	$ 234	$ 235

XML

Note 6 - Acquisitions (Details Textual) - USD ($) $ in Thousands	3 Months Ended
	Apr. 03, 2021	Mar. 28, 2020
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High	$ 3,100
Payment for Contingent Consideration Liability, Financing Activities	$ 0	$ 0

XML

Note 6 - Acquisitions - Maximum Deferred Consideration Payments (Details) $ in Thousands	Apr. 03, 2021 USD ($)
January 1, 2022 (after April 3, 2021)	$ 520
December 31, 2022	2,364
Estimated future contingent consideration payments	$ 2,884

XML

Note 7 - Goodwill (Details Textual) - USD ($) $ in Thousands	3 Months Ended
	Apr. 03, 2021	Mar. 28, 2020
Goodwill, Impairment Loss	$ 0	$ 0

XML

Note 7 - Goodwill - Changes in Carrying Amount of Goodwill (Details) - USD ($) $ in Thousands	Apr. 03, 2021	Jan. 02, 2021
Goodwill	$ 16,354	$ 16,354
Engineering [Member]
Goodwill	11,918
Specialty Health Care [Member]
Goodwill	2,398
Information Technology [Member]
Goodwill	$ 2,038

XML

Note 8 - Intangible Assets (Details Textual) - USD ($) $ in Thousands	3 Months Ended
	Apr. 03, 2021	Mar. 28, 2020
Impairment of Intangible Assets (Excluding Goodwill), Total	$ 0
Amortization of Intangible Assets, Total	$ 80	$ 80

XML

Note 8 - Intangible Assets - Intangible Assets by Class (Details) - USD ($) $ in Thousands	Apr. 03, 2021	Jan. 02, 2021
Intangible assets, net	$ 15	$ 95
Restricted Covenants [Member]
Intangible assets, net	8	12
Customer Relationships [Member]
Intangible assets, net	$ 7	$ 83

XML

Note 9 - Line of Credit (Details Textual) - USD ($) $ in Thousands	Sep. 29, 2020	Apr. 03, 2021	Jan. 02, 2021	Mar. 28, 2020	Oct. 18, 2019
Long-term Line of Credit, Noncurrent		$ 22,029	$ 11,890
Note Issued to Acquire Treasury Stock [Member]
Repayments of Subordinated Debt, Total	$ 2,200
Citizens Bank of Pennsylvania [Member] | Revolving Credit Facility [Member]
Line of Credit Facility, Maximum Borrowing Capacity					$ 45,000
Debt Instrument, Interest Rate, Effective Percentage		2.40%		3.70%
Long-term Line of Credit, Noncurrent		$ 22,000	11,900
Letters of Credit Outstanding, Amount		1,900	1,900
Line of Credit Facility, Remaining Borrowing Capacity		$ 21,100	$ 31,200

XML

Note 10 - Per Share Data (Details Textual) - shares shares in Thousands	3 Months Ended
	Apr. 03, 2021	Mar. 28, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)	0	0

XML

Note 10 - Per Share Data - Weighted Average Number of Common Shares (Details) - shares	3 Months Ended
	Apr. 03, 2021	Mar. 28, 2020
Basic weighted average shares outstanding (in shares)	11,539,389	13,111,550
Dilutive effect of outstanding restricted share awards (in shares)	389,857
Weighted average dilutive shares outstanding (in shares)	11,929,246	13,111,550

XML

Note 10 - Per Share Data - Unissued Shares of Common Stock Were Reserved for the Following Purposes (Details) - shares	Apr. 03, 2021	Jan. 02, 2021
Future grants of options or shares (in shares)	209,180	520,929
Shares reserved for employee stock purchase plan (in shares)	95,988	149,894
Total (in shares)	1,094,026	1,380,628
Time-based Restricted Stock Units [Member]
Time-based restricted stock units outstanding (in shares)	506,554	459,805
Unvested Subscription Restricted Share Awards [Member]
Time-based restricted stock units outstanding (in shares)	192,304	250,000
Performance-based Restricted Stock Units [Member]
Time-based restricted stock units outstanding (in shares)	90,000

XML

Note 11 - Share Based Compensation (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	3 Months Ended		12 Months Ended
	Dec. 31, 2020	Apr. 03, 2021	Mar. 28, 2020	Jan. 02, 2021	Dec. 29, 2018	Dec. 31, 2016	Dec. 27, 2015	Apr. 01, 2021	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year)				10 years
Share-based Payment Arrangement, Expense		$ 362	$ 69
Common Stock, Capital Shares Reserved for Future Issuance (in shares)		1,094,026		1,380,628
Dividends Payable		$ 0
Share Price (in dollars per share)								$ 3.75
The 2014 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares)						1,975,000			625,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized (in shares)				850,000		500,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in shares)		209,180
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted in Period, Fair Value		$ 835	$ 423
Employee Stock Purchase Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in shares)		95,988
Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date				85.00%
Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate		10.00%
Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee (in shares)		3,000
Additional Shares of Common Stock Reserved for Future Issuance (in shares)					300,000		300,000
Common Stock, Capital Shares Reserved for Future Issuance (in shares)					1,400,000		1,100,000
Stock Issued During Period, Shares, Employee Stock Purchase Plans (in shares)		53,906
Performance-based Restricted Stock Units [Member] | The 2014 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance (in shares)		90,000
Dividends Payable		$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)		90,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)		$ 3.26
Time-based Restricted Stock Units [Member]
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total		$ 1,100
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)		2 years
Time-based Restricted Stock Units [Member] | Immediately Vested [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)		125,000		100,092
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)		$ 2.17		$ 1.33
Time-based Restricted Stock Units [Member] | Senior Management [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)	250,000
Time-based Restricted Stock Units [Member] | The 2014 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance (in shares)		698,858		709,805
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total		$ 1,100
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested		$ 2,600
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)		96,749
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)		$ 2.80
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)		1 year
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)		3 years

XML

Note 11 - Share Based Compensation - Restricted Stock Units Activity (Details) - The 2014 Plan [Member]	3 Months Ended
	Apr. 03, 2021 $ / shares shares
Time-based Restricted Stock Units [Member]
Outstanding non-vested (in shares) | shares	709,805
Outstanding non-vested, weighted average grant date fair value (in dollars per share) | $ / shares	$ 1.92
Granted (in shares) | shares	96,749
Granted, weighted average grant date fair value (in dollars per share) | $ / shares	$ 2.80
Vested (in shares) | shares	(107,696)
Vested, weighted average grant date fair value (in dollars per share) | $ / shares	$ 2.21
Forfeited or expired (in shares) | shares
Forfeited or expired, weighted average grant date fair value (in dollars per share) | $ / shares
Outstanding non-vested (in shares) | shares	698,858
Outstanding non-vested, weighted average grant date fair value (in dollars per share) | $ / shares	$ 2
Performance-based Restricted Stock Units [Member]
Outstanding non-vested (in shares) | shares
Outstanding non-vested, weighted average grant date fair value (in dollars per share) | $ / shares
Granted (in shares) | shares	90,000
Granted, weighted average grant date fair value (in dollars per share) | $ / shares	$ 3.26
Vested (in shares) | shares
Vested, weighted average grant date fair value (in dollars per share) | $ / shares
Forfeited or expired (in shares) | shares
Forfeited or expired, weighted average grant date fair value (in dollars per share) | $ / shares
Outstanding non-vested (in shares) | shares	90,000
Outstanding non-vested, weighted average grant date fair value (in dollars per share) | $ / shares	$ 3.26

XML

Note 12 - Treasury Stock Transactions (Details Textual) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended
	Apr. 03, 2021	Mar. 28, 2020	Jan. 13, 2021
Treasury Stock, Shares, Acquired (in shares)	344,172	0
Treasury Stock Acquired, Average Cost Per Share (in dollars per share)	$ 2.65
Stock Repurchase Program, Remaining Authorized Repurchase Amount	$ 6.6
Maximum [Member]
Stock Repurchase Program, Authorized Amount			$ 7.5

XML

Note 14 - Segment Information - Results of the Segments (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 03, 2021	Mar. 28, 2020	Jan. 02, 2021
Revenues	$ 44,549	$ 45,033
Cost of services	33,699	34,190
Gross profit	10,850	10,843
Selling, general and administrative	9,069	10,237
Depreciation and amortization of property and equipment	266	255
Amortization of acquired intangible assets	80	80
Tax credit professional fees	60
Operating income (loss)	1,375	(7,776)
Total assets	77,770	83,951	$ 68,339
Capital expenditures	47	35
Depreciation and amortization	346	335
Write-off of receivables related to arbitration		8,047
Engineering [Member]
Revenues	14,466	14,163
Cost of services	11,260	10,205
Gross profit	3,206	3,958
Selling, general and administrative	3,074	3,424
Depreciation and amortization of property and equipment	156
Amortization of acquired intangible assets	80
Tax credit professional fees
Operating income (loss)	(104)	(7,751)
Total assets	35,898	43,690
Capital expenditures	9	9
Depreciation and amortization		238
Write-off of receivables related to arbitration		8,047
Specialty Health Care [Member]
Revenues	21,137	22,197
Cost of services	16,099	17,812
Gross profit	5,038	4,385
Selling, general and administrative	4,064	4,400
Depreciation and amortization of property and equipment	82
Amortization of acquired intangible assets
Tax credit professional fees
Operating income (loss)	892	(92)
Total assets	26,111	25,499
Capital expenditures	28	10
Depreciation and amortization		77
Write-off of receivables related to arbitration
Information Technology [Member]
Revenues	8,946	8,673
Cost of services	6,340	6,173
Gross profit	2,606	2,500
Selling, general and administrative	1,931	2,413
Depreciation and amortization of property and equipment	28
Amortization of acquired intangible assets
Tax credit professional fees
Operating income (loss)	647	67
Total assets	8,385	8,717
Capital expenditures	6	15
Depreciation and amortization		20
Write-off of receivables related to arbitration
Corporate Segment [Member]
Revenues
Cost of services
Gross profit
Selling, general and administrative
Depreciation and amortization of property and equipment
Amortization of acquired intangible assets
Tax credit professional fees	60
Operating income (loss)	(60)
Total assets	7,376	6,045
Capital expenditures	$ 4	1
Depreciation and amortization
Write-off of receivables related to arbitration

XML

Note 14 - Segment Information - Revenues by Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 03, 2021	Mar. 28, 2020
Revenue	$ 44,549	$ 45,033
UNITED STATES
Revenue	39,007	39,176
CANADA
Revenue	3,385	4,002
PUERTO RICO
Revenue	1,515	1,202
SERBIA
Revenue	$ 642	$ 653

XML

Note 14 - Segment Information - Total Assets by Geographic Area (Details) - USD ($) $ in Thousands	Apr. 03, 2021	Jan. 02, 2021	Mar. 28, 2020
Total assets	$ 77,770	$ 68,339	$ 83,951
UNITED STATES
Total assets	64,680	56,308
CANADA
Total assets	7,720	7,067
PUERTO RICO
Total assets	1,669	1,483
SERBIA
Total assets	$ 3,701	$ 3,481

XML

Note 15 - Income Taxes (Details Textual) - USD ($) $ in Thousands	3 Months Ended
	Apr. 03, 2021	Mar. 28, 2020
Income Tax Expense (Benefit), Total	$ 356	$ (2,240)
Effective Income Tax Rate Reconciliation, Percent, Total	26.10%	27.40%
Domestic Tax Authority [Member] | Internal Revenue Service (IRS) [Member]
Effective Income Tax Rate Reconciliation, Percent, Total	28.00%	27.00%
Foreign Tax Authority [Member] | Canada Revenue Agency [Member]
Effective Income Tax Rate Reconciliation, Percent, Total	26.50%	28.10%
Foreign Tax Authority [Member] | Ministry of Finance, Republic of Serbia [Member]
Effective Income Tax Rate Reconciliation, Percent, Total	15.10%	15.50%

XML

Note 16 - Contingencies (Details Textual) $ in Millions	Apr. 03, 2021 USD ($)
Estimated Litigation Liability	$ 1.8
Loss Contingency, Estimate of Possible Loss	2.0
Class Action Suit for Unpaid Overtime Wages to Travel Nurses [Member]
Estimated Litigation Liability	$ 1.7

XML

Note 17 - Leases - Lease Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 03, 2021	Mar. 28, 2020
Operating lease cost	$ 537	$ 656
Amortization of right of use assets	91	78
Finance lease cost, Interest on lease liabilities	2	2
Total finance lease cost	$ 93	$ 80

XML

Note 17 - Leases - Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 03, 2021	Mar. 28, 2020
Operating cash flows from operating leases	$ 552	$ 663
Operating cash flows from finance leases	1	2
Financing cash flows from finance leases	74	80
Operating leases	145	250
Finance leases

XML

Note 17 - Leases - Balance Sheet Information (Details) - USD ($) $ in Thousands	Apr. 03, 2021	Jan. 02, 2021
Operating lease right of use assets	$ 2,263	$ 2,409
Operating right of use liability - current	(1,937)	(1,886)
Operating right of use liability - non-current	(2,224)	(2,641)
Total operating lease liabilities	(4,161)	(4,527)
Property and equipment - (right of use assets)	1,140	1,140
Accumulated depreciation	(837)	(746)
Property and equipment, net	303	394
Finance lease liability - current	(183)	(247)
Finance lease liability - non-current	(96)	(106)
Total finance lease liabilities	$ (279)	$ (353)
Operating leases (years) (Year)	1 year 131 days	2 years 10 days
Finance leases (years) (Year)	1 year 156 days	1 year 164 days
Operating leases	3.08%	4.06%
Finance leases	2.88%	2.63%

XML

Note 17 - Leases - Maturities of Lease Liabilities (Details) - USD ($) $ in Thousands	Apr. 03, 2021	Jan. 02, 2021
2021 (after April 3, 2021), operating leases	$ 1,574
2021, finance leases	180
2022, operating leases	1,532
2022, finance leases	108
2023, operating leases	967
2023, finance leases
2024, operating leases	233
2024, finance leases
2025, operating leases	48
2025, finance leases
Total lease payments, operating leases	4,354
Total lease payments, finance leases	288
Less: imputed interest, operating leases	(193)
Less: imputed interest, finance leases	(9)
Total, operating leases	4,161	$ 4,527
Total, finance leases	$ 279	$ 353

XML

Note 18 - Stockholder Rights Plan (Details Textual) - $ / shares	May 22, 2020	Apr. 03, 2021	Jan. 02, 2021
Preferred Stock, Shares Authorized (in shares)		5,000,000	5,000,000
Preferred Stock, Par or Stated Value Per Share (in dollars per share)		$ 1	$ 1
Preferred Stock, Shares Issued, Total (in shares)		0	0
Minimum Percent of Common Stock to be Purchased for Rights to Become Exercisable	10.00%
Preferred Stock, Shares Outstanding, Ending Balance (in shares)		0	0
Series A-3 Junior Participating Preferred Shares [Member]
Preferred Stock, Shares Authorized (in shares)	250,000
Preferred Stock, Par or Stated Value Per Share (in dollars per share)	$ 1
Preferred Stock, Shares Issued, Total (in shares)	0
Preferred Stock, Dividend Rate, Per-Dollar-Amount (in dollars per share)	$ 50
Preferred Stock, Redemption Price Multiplier	100
Preferred Stock, Shares Outstanding, Ending Balance (in shares)	0
Series A-3 Junior Participating Preferred Shares [Member] | Voluntary or Involuntary Liquidation, Dissolution or Winding up of the Company [Member]
Preferred Stock, Redemption Price Multiplier	100
Preferred Stock, Redemption Price Per Share (in dollars per share)	$ 100
Series A-3 Junior Participating Preferred Shares [Member] | Consolidation, Merger, Combination or Other Transaction in which Shares of Common Stock are Exchanged [Member]
Preferred Stock, Redemption Price Multiplier	100
Right [Member]
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right (in shares)	1
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)	$ 5.60
Class of Warrant or Right, Price Per Right (in dollars per share)	$ 0.001